LiveOne (LVO) S-1/A 14 Jun 17 IPO registration (amended) Financial data

Document and Entity Information

Document and Entity Information	12 Months Ended
	Mar. 31, 2017
Document and Entity Information [Abstract]
Entity Registrant Name	LOTON, CORP
Entity Central Index Key	1,491,419
Trading Symbol	LIVX
Amendment Flag	false
Document Type	S1
Document Period End Date	Mar. 31, 2017
Entity Filer Category	Smaller Reporting Company

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Mar. 31, 2017	Mar. 31, 2016
Current Assets
Cash and cash equivalents	$ 1,477,229	$ 36,898
Prepaid expense	21,569	15,995
Total Current Assets	1,498,798	52,893
Other Assets
Fixed assets, net	57,407	62,569
Investment in OCHL		4,889,515
Note receivable - related party		213,331
Total Assets	1,556,205	5,218,308
Current Liabilities
Accounts payable and accrued liabilities	542,035	481,412
Note payable	277,270	262,042
Due to related parties		117,124
Accrued interest, related party		232,733
Note payable, shareholder	3,603,446	2,784,000
Current portion of unsecured convertible notes, net of discount	67,858
Services payable, related party	239,080	1,000,000
Total Current Liabilities	4,729,689	4,877,311
Unsecured convertible notes - related party, net of discount	11,668
Unsecured convertible notes, net of discount and current portion	220,540	110,273
Total Liabilities	4,961,897	4,987,584
Stockholders' Equity (Deficit)
Preferred stock, $0.001 par value; 1,000,000 shares authorized; no shares issued or outstanding
Common stock, $0.001 par value; 500,000,000 shares authorized; 103,996,974 and 91,996,976 shares issued and outstanding, respectively	103,997	91,997
Additional paid in capital	24,586,201	13,984,898
Accumulated deficit	(28,095,890)	(13,846,171)
Total stockholders' equity (deficit)	(3,405,692)	230,724
Total Liabilities and Stockholders' Equity (Deficit)	$ 1,556,205	$ 5,218,308

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2017	Mar. 31, 2016
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, authorized	1,000,000	1,000,000
Preferred stock, issued
Preferred stock, outstanding
Common stock, par value	$ 0.001	$ 0.001
Common stock, authorized	500,000,000	500,000,000
Common stock, issued	103,996,974	91,996,976
Common stock, outstanding	103,996,974	91,996,976

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Income Statement [Abstract]
Revenue	$ 225,000
Operating expenses:
Selling, general and administrative	5,349,801	3,619,000
Related party expenses	360,000	360,000
Total operating expenses	5,709,801	3,979,000
Loss from operations	(5,484,801)	(3,979,000)
Other income (expense):
Interest expense, net	(512,152)	(178,498)
Other income	6,667
Fair value of warrants issued for note extension and inducement to convert	(2,002,977)
Earnings from investment in OCHL	132,832	410,553
Fair value of warrants and beneficial conversion features on debt conversion	(3,248,948)
Fair value of beneficial conversion feature	(136,936)
Impairment of note receivable - related party	(213,331)
Loss on sale of investment in OCHL	(2,790,073)
Total other income (expense)	(8,764,918)	232,055
Net loss	$ (14,249,719)	$ (3,746,944)
Net loss per share - basic and diluted	$ (0.15)	$ (0.04)
Weighted average common shares - basic and diluted	97,596,206	90,082,796

Consolidated Statement of Stock

Consolidated Statement of Stockholders' Equity - USD ($)	Total	Common stock [Member]	Additional Paid in Capital [Member]	Accumulated Deficit [Member]
Balance at beginning at Mar. 31, 2015	$ 2,403,311	$ 88,270	$ 12,414,268	$ (10,099,227)
Balance at beginning (in shares) at Mar. 31, 2015		88,269,976
Shares issued for cash	612,500	$ 763	611,737
Shares issued for cash, Shares		762,500
Shares issued for services and advisory board	856,500	$ 1,802	854,698
Shares issued for services and advisory board, Shares		1,802,000
Shares issued for warrants	5,813	$ 1,162	4,651
Shares issued for warrants, Shares		1,162,500
Debt discount	99,544		99,544
Net loss	(3,746,944)			(3,746,944)
Balance at ending at Mar. 31, 2016	230,724	$ 91,997	13,984,898	(13,846,171)
Balance at ending (in shares) at Mar. 31, 2016		91,996,976
Shares issued for cash	1,375,000	$ 550	1,374,450
Shares issued for cash, Shares		550,000
Net loss	(14,249,719)			(14,249,719)
Fair value of shares issued for services	2,279,589	$ 1,579	2,278,010
Fair value of shares issued for services, Shares		1,578,720
Shares issued upon exercise of warrants	48,123	$ 9,665	38,458
Shares issued upon exercise of warrants, Shares		9,665,360
Share issued upon debt conversion	205,918	$ 206	205,712
Share issued upon debt conversion, Shares		205,918
Fair value of warrants and beneficial conversion features as valuation discount	1,315,812		1,315,812
Fair value of warrants and beneficial conversion features on debt conversion	3,248,948		3,248,948
Fair value of warrants issued for note extension and inducement to convert	2,002,977		2,002,977
Fair value of beneficial conversion feature	136,936		136,936
Balance at ending at Mar. 31, 2017	$ (3,405,692)	$ 103,997	$ 24,586,201	$ (28,095,890)
Balance at ending (in shares) at Mar. 31, 2017		103,996,974

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash Flows from Operating Activities
Net loss	$ (14,249,719)	$ (3,746,944)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	24,115	6,336
Common stock issued for services	2,279,589	856,500
Amortization of debt discount	251,750	9,817
Fair value for beneficial conversion feature	136,936
Fair value of warrants and beneficial conversion features on debt conversion	3,248,948
Fair value for warrants issued for note extension and inducement to convert	2,002,977
Equity in earnings of OCHL	(132,832)	(410,553)
Loss on sale of investment in OCHL	2,790,073
Impairment of note receivable	213,331
Changes in operating assets and liabilities:
(Increase)/Decrease in prepaid expenses	(5,574)	(15,185)
Decrease/(Increase) in accrued interest	252,517	15,779
Decrease/(Increase) in accounts payable and accrued liabilities	64,720	284,308
Net cash used in operating activities	(3,123,169)	(2,999,942)
Cash Flows from Investing Activities:
Purchases of fixed assets	(18,953)	(58,013)
Sale of investment	2,182,274
Note receivable, former affiliate		281,418
Net cash provided by investing activities	2,163,321	223,405
Cash Flows from Financing Activities
Proceeds from notes payable, related party	820,100	1,959,000
Repayment of note payable, related party	(450,000)
Proceeds from convertible notes	1,385,000	200,000
Repayment of convertible notes, related party	(55,000)
Proceeds from convertible notes, related party	105,000
Proceeds from warrant exercise	48,123
Proceeds from issuance of common stock	1,375,000	618,314
Repayment of services payable, related party	(750,000)
Proceeds from loans, related party	(78,044)
Net cash provided by financing activities	2,400,179	2,777,314
Net Increase/(Decrease) in cash	1,440,331	777
Cash, beginning of period	36,898	36,121
Cash, end of period	1,477,229	36,898
Supplemental disclosure of non-cash investing and financing activities:
Fair value for warrants and beneficial conversion features issued as valuation discount	1,315,814
Conversion of accrued interest on first and second senior notes into unsecured convertible note	430,565
Common stock issued upon conversion of note payable	$ 205,918

Organization, Operations and Ba

Organization, Operations and Basis of Presentation	12 Months Ended
	Mar. 31, 2017
Organization, Operations and Basis of Presentation [Abstract]
Organization, Operations and Basis of Presentation	Note 1 – Organization, Operations and Basis of Presentation Business and Operations Loton, Corp (“we,”“our” or the “Company”) was incorporated under the laws of the State of Nevada on December 28, 2009. LiveXLive, Corp. (“LiveXLive”), its wholly owned subsidiary, was incorporated under the laws of the State of Delaware on February 24, 2015. The Company is one of the world's only premium internet networks devoted to live music and music-related video content. Since LiveXLive's launch in 2015, it has been building an online destination for music fans to enjoy premium live performances from music venues and leading music festivals around the world, such as Rock in Rio, Hangout Music Festival and Outside Lands Music and Arts Festival, as well as premium original content, artist exclusives and industry interviews. The LiveXLive platform has featured performances and content from some of the most popular artists in various music genres, including Rihanna, Katy Perry, Radiohead, Metallica, Duran Duran, Chance The Rapper, Bruce Springsteen, Major Lazer and Maroon 5. Forward Stock Split In September 2016, the Company’s Board of Directors declared a 2-for-1 forward stock split of the Company’s common stock in the form of a dividend. All shares and per-share amounts have been restated as of the earliest period presented to reflect the stock split. Going Concern The Company’s consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business. As reflected in its consolidated financial statements, the Company had a stockholders’ deficit of $3,405,692 at March 31, 2017, incurred a net loss of $14,249,719, and utilized net cash of $3,123,169 in operating activities for the fiscal year then ended. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year from the date that the financial statements are issued. The Company’s consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. Management estimates that the current funds on hand will be sufficient to continue operations through September 2017. The Company’s ability to continue as a going concern is dependent on its ability to execute its strategy and on its ability to raise additional funds and/or to consummate a public offering. Management is currently seeking additional funds, primarily through the issuance of equity and/or debt securities for cash to operate the Company’s business, including a public offering. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to it. Even if we are able to obtain additional financing, it may contain undue restrictions on its operations, in the case of debt financing or cause substantial dilution for its stockholders, in case of equity and/or convertible debt financing. Furthermore, no assurance can be given that a public offering will be consummated.

Significant Accounting Policies

Significant Accounting Policies and Practices	12 Months Ended
	Mar. 31, 2017
Significant Accounting Policies and Practices [Abstract]
Significant Accounting Policies and Practices	Note 2 - Significant Accounting Policies and Practices Revenue Recognition Policy The Company recognizes revenue from its live events and show productions when all of the following criteria are met: (i) persuasive evidence of an arrangement exists, (ii) the show or live event has been completed and occurred and there are no future production obligations, (iii) the sales price is fixed or determinable, and (iv) collectability is reasonably assured. Use of Estimates and Assumptions The preparation of financial statements in conformity with generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date(s) of the financial statements and the reported amounts of revenues and expenses during the reporting period(s). Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Management regularly evaluates the key factors and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates. Significant estimates include those related to assumptions used in impairment testing of long term assets, accruals for potential liabilities, assumptions made in valuing equity instruments issued for services and issued with convertible notes, and recognition of deferred tax assets. Actual results could differ from those estimates. Principles of Consolidation The Company’s consolidated subsidiaries and/or entities are as follows: Name of consolidated subsidiary or entity State or other Date of Attributable LiveXLive Tickets, Inc. Delaware April 24, 2017 100% LXL Studios, Inc. Delaware July 15, 2016 100% LiveXLive, Corp. Delaware February 24, 2015 100% KOKO (Camden) Holdings (US), Inc. Delaware March 17, 2014 100% KOKO (Camden) UK Limited England and Wales November 7, 2013 100% The Company’s consolidated financial statements include all accounts of the Company and its consolidated subsidiaries and/or entities as of reporting period ending date(s) and for the reporting period(s) then ended, except for LiveXLive Tickets, Inc., as it was formed after March 31, 2017. All inter-Company balances and transactions have been eliminated. Fair Value of Financial Instruments The Company follows the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) for disclosures about fair value of its financial instruments and to measure the fair value of its financial instruments. The FASB ASC establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The three levels of fair value hierarchy are described below: Level 1 Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. Level 2 Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3 Pricing inputs that are generally observable inputs and not corroborated by market data. Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable. The carrying amounts of the Company’s financial assets and liabilities, including cash, prepaid expenses, accounts payable, accrued expenses, and other current liabilities, approximate their fair values because of the short maturity of these instruments. The fair value of notes payable and convertible notes approximate their fair values since the current interest rates and terms on these obligations are the same as prevailing market rates. Investment in Unconsolidated Subsidiary Under the Equity Method The Company accounts for investments in which the Company owns more than 20% of the investee using the equity method in accordance with ASC Topic 323, Investments — Equity Method and Joint Ventures Stock-Based Compensation The Company periodically issues stock warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock warrant grants issued and vesting to employees based on the authoritative guidance provided by FASB where the value of the award is measured on the date of grant and recognized as compensation expense on the straight-line basis over the vesting period. The Company accounts for stock warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the FASB where the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. In certain circumstances where there are no future performance requirements by the non-employee, warrants grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date. The fair value of the Company's stock warrant grants are estimated using the Black-Scholes-Merton Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or warrants, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model, and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods. In light of the very limited trading of the our common stock, market value of the shares issued was determined based on the then most recent price per share at which we sold common stock in a private placement during the periods then ended. Income Taxes The Company follows the asset and liability method which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are based on the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the Statements of Operations in the period that includes the enactment date. Loss Per Share Basic loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted loss per share reflects the potential dilution, using the treasury stock method that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the loss of the Company. In computing diluted loss per share, the treasury stock method assumes that outstanding options and warrants are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. At March 31, 2017 and 2016, the Company had 150,000 and 3,600,000 warrants outstanding, respectively, and 3,028,325 and 410,260 shares issuable for our convertible note payables, respectively, which were excluded from the loss per share calculation, as they were anti-dilutive. Recently Issued Accounting Pronouncements In May 2014, the FASB issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers In February 2016, the FASB issued ASU No. 2016-02, Leases Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the SEC did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statement presentation or disclosures.

Equity Investment in OCHL

Equity Investment in OCHL	12 Months Ended
	Mar. 31, 2017
Equity Investments in OCHL [Abstract]
Equity Investments in OCHL	Note 3 – Equity Investment in OCHL On April 28, 2014, the Company acquired a 50% equity interest in Obar Camden Holdings Limited (“OCHL”), an entity that owns Obar Camden Limited (“OCL”), a music and entertainment company whose principal business is the operation of a live music venue and nightclub known as KOKO, located in Camden, London. KOKO provides live shows, club nights, corporate and other events. The Company acquired its 50% interest through the issuance of 58,000,000 shares of its common stock to the seller, JJAT Corp. (“JJAT”), a Delaware corporation wholly owned by Mr. Robert Ellin, the Company’s Executive Chairman, President, director and majority stockholder, and his affiliates. Since both the Company and JJAT were controlled by Mr. Ellin at the time of this transaction, the transaction was accounted for as a transaction between related parties at the related parties’ original basis. Accordingly, the Company recorded the equity method investment at $4.2 million which is JJAT’s historical basis in OCHL. As part of the transaction, the Company was to be reimbursed $494,750 by OCHL for legal and other acquisition costs incurred in relation to the acquisition of the 50% interest, which obligated was evidenced by a promissory note. As of March 31, 2016, the outstanding advance and any interest due thereunder to the Company was $213,331. The Company and the various parties to the agreement had certain disputes. On September 22, 2016, Mr. Olly Bengough, the Company’s former Chief Executive Officer and director (“Bengough”), entered into a Settlement Agreement (the “Settlement Agreement”) with the Company and Mr. Ellin. On November 24, 2016, $2,182,274 was paid to the Company as the final sale price and the rest of the transactions contemplated under the Settlement Agreement were automatically consummated (including the Company’s sale of its interest in OCHL to Bengough). As a result, the Company recognized a loss of $2,790,073 for the remaining investment balance. As part of such transactions, Bengough was released from his obligation under the note described above and therefore, the Company recognized a loss on impairment of the note of $213,331 (See Note 10). As of November 24, 2016, the change in the investment in the affiliate was as follows: Balance as of March 31, 2015 $ 4,478,962 50% share of net income for the period 410,553 Balance as of March 31, 2016 4,889,515 50% share of net income for the period 132,832 Balance as of November 24, 2016 5,022,347 Proceeds received (2,182,274 ) Liability extinguished (50,000 ) Loss recognized $ 2,790,073 Net income from OCHL for the period from April 1, 2016 through November 24, 2016, and the fiscal year ended March 31, 2016, was as follows: Period from April 1, November 24, 2016 Fiscal Year Ended Revenue $ 3,921,204 $ 6,754,707 Cost of revenue 546,480 920,667 Gross profit 3,374,724 5,834,040 Operating expenses Selling, general and administrative 2,893,306 4,613,058 Depreciation and amortization 74,828 133,106 Total operating expenses 2,968,134 4,746,164 Income from operations before other expenses 406,590 1,087,876 Other expenses Interest 28,002 45,997 Income before provision for taxes 378,588 1,041,879 Taxes 112,924 220,773 Net income $ 265,664 $ 821,105 The carrying amounts of the major classes of assets and liabilities of OCHL as of March 31, 2016 was follows March 31, Assets Current assets Cash and cash equivalents $ 386,009 Accounts receivable 24,743 Inventory 62,548 Prepaid expenses and other current assets 533,128 Total current assets 1,006,429 Other assets Property and equipment, net of accumulated depreciation 867,975 Total assets $ 1,874,205 Liabilities and Shareholders’ Deficit Current liabilities Accounts payable $ 514,488 Taxes payable 410,504 Notes payable, current 207,978 Other accrued liabilities 460,290 Total current liabilities 1,593,210 Deferred rent – noncurrent 937,459 Total liabilities 2,530,669 Shareholders deficit (656,464 ) Total Liabilities and Shareholders’ Deficit $ 1,874,205

Property and Equipment

Property and Equipment	12 Months Ended
	Mar. 31, 2017
Property and Equipment [Abstract]
Property and Equipment	Note 4 — Property and Equipment Property and equipment at March 31, 2017 and 2016 was as follows: March 31, March 31, Production equipment $ 51,304 $ 51,304 Computer equipment 42,078 23,125 Total property and equipment 93,382 74,429 Accumulated depreciation (35,975 ) (11,860 ) Property and equipment, net $ 57,407 $ 62,569 Depreciation expense was $24,115 and $6,336 for the years ended March 31, 2017 and 2016, respectively.

Notes Payable to Major Stockhol

Notes Payable to Major Stockholder	12 Months Ended
	Mar. 31, 2017
Notes Payable to Major Stockholder [Abstract]
Notes Payable to Major Stockholder	Note 5 — Notes Payable to Major Stockholder As of March 31, 2017 and 2016, the Company had the following outstanding notes payable to Trinad Capital Master Fund (“Trinad Capital”), a fund wholly owned by Mr. Ellin, the Company’s Executive Chairman, President, director and majority stockholder, for both short and long term working capital requirements: March 31, March 31, (A) First Senior Note $ - $ 1,000,000 (B) Second Senior Note - 1,784,000 (C) 6% Unsecured Convertible Note 3,603,446 - Total $ 3,603,446 $ 2,784,000 (A) First Senior Note — Trinad Capital Master Fund On December 31, 2014, the Company entered into a senior convertible promissory note (the “First Senior Note”) with Trinad Capital allowing for advances up to a maximum loan amount of $1,000,000, plus interest at the rate of 6% per annum on the unpaid principal amount of outstanding advances. At the time the First Senior Note was made, Trinad Capital advanced $700,000 to the Company and had accrued $70,151 in unpaid interest. Pursuant to the terms of the Senior Note, all outstanding unpaid principal and accrued interest was originally due and payable on June 30, 2016 or such later date as Trinad Capital may agree to in writing unless, prior to such date, the First Senior Note has been repaid in full or Trinad Capital elects to convert all or any portion of the then-outstanding loan balance into common stock of the Company in connection with the Company consummating an equity financing in excess of $5,000,000 or greater as set forth in the terms of the First Senior Note. Subsequent to the making of the First Senior Note: ● On January 27, 2015, the Company and Trinad Capital entered into an amendment to the First Senior Note, effective as of December 31, 2014, pursuant to which: (1) the term of the First Senior Note was extended to June 30, 2016 and (2) the conversion price for conversion of the unpaid balance and interest outstanding in connection with an equity financing was amended to be the price per share equal to the average price per share paid by investors in such equity financing; ● On February 5, 2015, the Company and Trinad Capital amended and restated the First Senior Note, effective as of December 31, 2014, to eliminate the convertibility feature of the note was eliminated in its entirety; and ● On April 21, 2016, the First Senior Note was further amended to extend its maturity date to June 30, 2017, or such later date as Trinad Capital may agree to in writing. For extending the due date of the First Senior Note to June 30, 2017, the Company issued to Trinad Capital warrants to purchase 1,144,986 shares of its common stock, with an exercise price of $0.005 per share and expiration date of April 21, 2020. During the fiscal year ended March 31, 2017, these warrants were fully exercised. The aggregate fair value of the 1,144,986 warrants were valued at $567,282 using the Black-Scholes-Merton Option Pricing model with the following average assumptions: risk-free interest rate of 1.30%; dividend yield of 0%; volatility rate of 100%; and an expected life of four years (statutory term). The maturity date extension was considered to be a debt restructuring that is accounted for as a debt extinguishment. Therefore, the value of the warrants was expensed as of April 21, 2016. As of March 31, 2016, $1,000,000 of principal was outstanding under the First Senior Note and accrued interest $140,555 is reflected on the consolidated balance sheet as accrued interest payable, related party as of March 31, 2016. On February 21, 2017, aggregate principal and accrued interest of $1,197,897 due under this note was exchanged into a convertible note discussed below (C). (B) Second Senior Note — Trinad Capital Master Fund On April 8, 2015, the Company entered into a second senior promissory note (the “Second Senior Note”) with Trinad Capital in the amount of $195,500. The Second Senior Note bears interest at the rate of eight percent (8%) per annum and all outstanding unpaid principal and accrued interest is due and payable on June 30, 2016 or such later date as Trinad Capital may agree to in writing, unless prior to such date this note has been prepaid in full. During the year ended March 31, 2016, Trinad Capital made advances to the Company totaling $1,784,000. Subsequent to the making of the Second Senior Note: ● On July 10, 2015, the Second Senior Note was amended and restated to increase the principal amount from $195,500 to the lesser of (i) $1,000,000 (the “Maximum Advance Amount”), or (ii) the aggregate unpaid principal amount of the advances; ● On November 23, 2015, Second Senior Note was amended the Second Senior Note to increase the Maximum Advance Amount to $2,000,000; and ● On April 26, 2016, the Second Senior Note was amended to increase the Maximum Advance Amount to $3,000,000 and to extend the maturity date to June 30, 2017 or such later date as Trinad Capital may agree to in writing. For extending the due date of the Second Senior Note to June 30, 2017, the Company issued to Trinad Capital warrants to purchase 2,207,768 shares of its common stock, with an exercise price of $0.005 per share and expiration date of April 21, 2020. During the fiscal year ended March 31, 2017, these warrants were fully exercised. The aggregate fair value of the 2,207,768 warrants issued upon extension of the note were valued at $1,093,832 using the Black-Scholes-Merton Option Pricing model with the following average assumptions: risk-free interest rate of 1.30%; dividend yield of 0%; volatility rate of 100%; and an expected life of four years (statutory term). The maturity date extension was considered to be a debt restructuring that is accounted for as a debt extinguishment. Therefore, the value of the warrants was expensed as of April 21, 2016. The amount due to Trinad Capital under the Second Senior Note was $1,784,000 at March 31, 2016. During the year ended March 31, 2017, Trinad Capital made additional advances to the Company under the Second Senior Note totaling $820,100. The Company also made repayments of the Second Senior Note totaling $450,000 during year ended March 31, 2017. As of February 21, 2016, $2,154,100 of principal was outstanding under the Second Senior Note. Accrued interest of $87,048 is reflected on the balance sheet as accrued interest payable, related party as of March 31, 2016. On February 21, 2017, aggregate principal and accrued interest of $2,383,180 due under this note was exchanged into a convertible note discussed below (C). (C) 6% Unsecured Convertible Note — Trinad Capital Master Fund On February 21, 2017, the Company issued a 6% unsecured convertible note payable to Trinad Capital to convert aggregate principal and interest of $3,581,077 under the First and Second Senior Notes with Trinad Capital discussed above. This convertible note is due on March 31, 2018. Before its maturity, the noteholder shall in its sole discretion have the option to convert all outstanding principal and interest into the Company’s common stock at a conversion price per share based upon the Company’s current valuation, as determined by the Board of Directors. If the Company raises a minimum of $5,000,000 (excluding the amount converting pursuant to the note) of aggregate gross proceeds from an equity financing in one or more closings prior to the maturity date, Trinad Capital will have the right to convert all outstanding note principal and interest into the same equity securities issued in such equity financing at 75% of the issuance price of the securities issued in such financing. In addition, Trinad Capital received 1,790,539 warrants to purchase shares of the Company’s common stock at an exercise price of $0.01 per share. The warrants were exercised on February 28, 2017. The conversion of the First and Second Senior Notes into an unsecured convertible note and warrants was considered to be a debt restructuring that is accounted for as a debt extinguishment. The aggregate relative fair value of the 1,790,539 warrants issued to the noteholder was determined to be $1,624,474 using the Black-Scholes-Merton Option Pricing model with the following average assumptions: risk-free interest rate of 1.50%; dividend yield of 0%; volatility rate of 100%; and an expected life of three years (statutory term). As of February 21, 2016, the effective conversion price was $0.91, and the market price of the shares on the date of conversion was approximately $1.67 per share. As such, the Company recognized a beneficial conversion feature of $1,624,474. The relative fair value of the warrants and the note’s beneficial conversion feature totaling $3,248,948 was expensed as of March 31, 2017. At March 31, 2017, the balance of the note and accrued interest were $3,581,077 and $22,369, respectively.

Note Payable

Note Payable	12 Months Ended
	Mar. 31, 2017
Note Payable [Abstract]
Note Payable	Note 6 — Note Payable On December 31, 2014, the Company converted accounts payable into a Senior Promissory Note (the “Note”) in the aggregate principal amount of $242,498. The Note bears interest at 6% per annum and interest is payable on a quarterly basis commencing March 31, 2015 or the Company may elect that the amount of such interest be added to the principal sum outstanding under this Note. The payables arose in connection with professional services rendered by attorneys for the Company prior to and through December 31, 2014, and the Note had an original maturity date of December 31, 2015, which was extended to June 30, 2016 or such later date as the lender may agree to in writing. As of March 31, 2017 and 2016, the balance due was $277,270 and $262,040, which includes $34,772 and $19,542 of accrued interest, respectively, were outstanding under the Note, and is currently past due.

Related Party Unsecured Convert

Related Party Unsecured Convertible Notes Payable	12 Months Ended
	Mar. 31, 2017
Related Party Unsecured Convertible Notes Payable [Abstract]
Related Party Unsecured Convertible Notes Payable	Note 7 — Related Party Unsecured Convertible Notes Payable Related Party Unsecured convertible notes payable at March 31, 2017 and 2016 were as follows: (A) 6% Unsecured Convertible Note – due September 13, 2018 $ - $ - (B) 6% Unsecured Convertible Note – due on March 31, 2018 50,707 - Less accumulated amortization of Valuation Discount (39,039 ) - Net $ 11,668 $ - (A) Convertible Note — JJAT On August 19, 2016, the Company issued a 6% unsecured convertible note payable to a related party for total principal amount of $55,000. This note was due on September 30, 2018. Before its maturity, the noteholder had in its sole discretion have the option to convert all outstanding principal and interest into the Company’s common stock at a conversion price per share based upon the Company’s current valuation, as determined by the Board of Directors. If the Company raises a minimum of $5,000,000 (excluding the amount converting pursuant to the note) in the aggregate in gross proceeds from an equity financing led by a reputable institutional investor in one or more closings prior to the maturity date, the noteholder will have the right to convert all outstanding principal and interest into the same equity securities issued in such qualified equity financing at 75% of the issuance price of the securities in such financing. On December 21, 2016, this note was repaid. (B) Convertible Note — Marvin Ellin On January 4, 2017, the Company issued a 6% unsecured convertible note payable to a certain investor for total principal amount of $50,000. This note will be due on September 13, 2018. Before its maturity, the noteholder shall in its sole discretion have the option to convert all outstanding principal and interest into the Company’s common stock at a conversion price per share based upon the Company’s current valuation, as determined by the Board of Directors. If the Company raises a minimum of $5,000,000 (excluding the amount converting pursuant to the note) of aggregate gross proceeds from an equity financing in one or more closings prior to the maturity date, the noteholder will have the right to convert all outstanding note principal and interest into the same equity securities issued in such equity financing at 75% of the issuance price of the securities issued in such financing. In addition, the noteholder received 25,000 warrants to purchase shares of the Company’s common stock at an exercise price of $0.01 per share. The aggregate relative fair value of the 25,000 warrants issued to the investor was determined to be $22,681 using the Black-Scholes-Merton Option Pricing model with the following average assumptions: risk-free interest rate of 1.50%; dividend yield of 0%; volatility rate of 100%; and an expected life of three years (statutory term). As of February 21, 2017, the effective conversion price was $0.91, and the market price of the shares on the date of conversion was approximately $1.67 per share. As such, the Company recognized a beneficial conversion feature of $22,681. The aggregate value of the warrants and beneficial conversion feature of $45,362 was considered as debt discount upon issuance and will be amortized as interest over the term of the note or in full upon the conversion of the note. During year ended March 31, 2017, the Company amortized $6,323 of such discount to interest expense, and the unamortized discount as of March 31, 2017 was $39,039. As of March 31, 2017, $50,000 of principal and $707 of accrued interest was due under the note.

Unsecured Convertible Notes Pay

Unsecured Convertible Notes Payable	12 Months Ended
	Mar. 31, 2017
Unsecured Convertible Notes Payable [Abstract]
Unsecured Convertible Notes Payable	Note 8 — Unsecured Convertible Notes Payable Unsecured Convertible notes payable at March 31, 2017 and 2016 were as follows: March 31, March 31, (A) 8% Unsecured Convertible Notes – Due on January 19, 2018 $ — $ 200,000 (B) 6% Unsecured Convertible Notes – Due on September 13, 2018 154,882 — (C) 6% Unsecured Convertible Notes – Due between January 31, 2018 and September 30, 2018 1,248,267 — Total 1,403,149 200,000 Less accumulated amortization of Valuation Discount (1,114,751 ) (89,727 ) Net 288,398 110,273 Less note payable, current 67,858 — Notes payable, long-term $ 220,540 $ 100,273 (A) On January 19, 2016, the Company issued three 8% unsecured convertible notes payable to investors (the “Lenders”) for an aggregate amount of $200,000. These notes were due on January 19, 2018. Before the maturity date, the noteholder had in its sole discretion have the option to convert all outstanding principal and interest into the Company’s common stock at a conversion price per share based upon the Company’s current valuation, as determined by the Board of Directors. If the Company raises a minimum of $2,500,000 (excluding the amount converting pursuant to the notes) in the aggregate in gross proceeds from an equity financing led by a reputable institutional investor in one or more closings prior to the maturity date, the Lenders will have the right to convert all outstanding principal and interest into the same equity securities issued in such qualified equity financing at 75% of the issuance price of the securities in such financing. In addition, the Lenders received 400,000 warrants to purchase shares of the Company’s common stock at an exercise price of $0.005 per share. The warrants were exercised during the year ended March 31, 2017. The aggregate relative fair value of the 400,000 warrants issued to the Lender was determined to be $99,915 using the Black-Scholes-Merton Option Pricing model with the following average assumptions: risk-free interest rate of 1.30%; dividend yield of 0%; volatility rate of 100%; and an expected life of four years (statutory term). The value of the warrants of $99,915 was considered as debt discount upon issuance and was being amortized as interest over the term of the notes or in full upon the conversion of the corresponding notes. During the year ended March 31, 2016, the Company amortized $9,818 of such discount to interest expense, and the unamortized discount as of March 31, 2016 was $89,727. On June 6, 2016, the Lenders converted $200,000 of principal and $5,918 of interest into 205,918 shares of the Company’s common stock at a conversion price of $1 per share. As the market price of the shares on the date of conversion was approximately $1.67 per share, the Company recognized a beneficial conversion cost of $136,936. As a result of the conversion, the remaining debt discount of $89,727 was fully amortized to interest expense as of the date of conversion. As an inducement for the conversion, the Lenders were issued 205,920 warrants to purchase shares of the Company’s common stock at an exercise price of $0.005 per share. The aggregate fair value of the 205,920 warrants issued to the Lenders was $341,864 using the Black-Scholes-Merton Option Pricing model with the following average assumptions: risk-free interest rate of 1.20%; dividend yield of 0%; volatility rate of 100%; and an expected life of three years (statutory term). The value of the warrants of $341,864 was considered as additional interest expense upon their issuance. The warrants were exercised immediately into 205,920 shares of the Company’s common stock with net proceeds of $1,030 to the Company. (B) On September 14, 2016, the Company issued a 6% unsecured convertible note payable to a certain investor for total principal amount of $150,000. This note will be due on September 13, 2018. Before the maturity date, the noteholder shall in its sole discretion have the option to convert all outstanding principal and interest into the Company’s common stock at a conversion price per share based upon the Company’s current valuation, as determined by the Board of Directors. If the Company raises a minimum of $5,000,000 (excluding the amount converting pursuant to the note) of aggregate gross proceeds from an equity financing in one or more closings prior to the maturity date, the noteholder will have the right to convert all outstanding note principal and interest into the same equity securities issued in such equity financing at 75% of the issuance price of the securities issued in such financing. In addition, the noteholder received 150,000 warrants to purchase shares of the Company’s common stock at an exercise price of $0.005 per share. The aggregate relative fair value of the 150,000 warrants issued to the noteholder was determined to be $93,612 using the Black-Scholes-Merton Option Pricing model with the following average assumptions: risk-free interest rate of 0.90%; dividend yield of 0%; volatility rate of 100%; and an expected life of three years (statutory term). As of September 14, 2016, the effective conversion price was $0.63, and the market price of the shares on the date of conversion was approximately $1.67 per share. As such, the Company recognized a beneficial conversion feature of $56,388. As a result, the Company recorded a note discount of $150,000 to account for the relative fair value of the warrants and the notes’ beneficial conversion feature which will be amortized as interest over the term of the note. During year ended March 31, 2017, the Company amortized $40,741 of such discount to interest expense, and the unamortized discount as of March 31, 2017 was $109,259. As of March 31, 2017, $4,882 accrued interest was added to principal balance. (C) Between November 22, 2016 and March 27, 2017, the Company issued seven 6% unsecured convertible notes payable to certain investors for aggregate total principal of $1,235,000. The notes are due on various dates through September 30, 2018. Before the maturity date, the noteholders shall in their sole discretion have the option to convert all outstanding principal and interest into the Company’s common stock at a conversion price per share based upon the Company’s current valuation, as determined by the Board of Directors. If the Company raises a minimum of $5,000,000 (excluding the amount converting pursuant to the note) of aggregate gross proceeds from an equity financing in one or more closings prior to the maturity date, the noteholders will have the right to convert all outstanding note principal and interest into the same equity securities issued in such equity financing at 75% of the issuance price of the securities issued in such financing. In addition, the noteholders received an aggregate of 617,500 warrants to purchase shares of the Company’s common stock at an exercise price of $0.01 per share. The aggregate relative fair value of the 617,500 warrants issued to the noteholders was determined to be $560,226 using the Black-Scholes-Merton Option Pricing model with the following average assumptions: risk-free interest rate of 1.35-1.53%; dividend yield of 0%; volatility rate of 100%; and an expected life of three years (statutory term). At the issuance of these notes, the effective conversion price was $0.91 and the market price of the shares on the date of conversion was approximately $1.67 per share, the Company recognized aggregate beneficial conversion features of $560,226. As a result, the Company recorded a note discount of $1,120,450 to account for the relative fair values of the warrants and the notes’ beneficial conversion features which will be amortized as interest over the terms of the notes or in full upon conversion of the notes. During year ended March 31, 2017, the Company amortized $114,961 of such discount to interest expense, and the unamortized discount as of March 31, 2017 was $1,004,590.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Mar. 31, 2017
Related Party Transactions [Abstract]
Related Party Transactions	Note 9 — Related Party Transactions Management Services from Trinad Management LLC Pursuant to a Management Agreement (the “Management Agreement”) with Trinad Management LLC (“Trinad LLC”) entered into on September 23, 2011, Trinad LLC agreed to provide certain management services to the Company through September 22, 2014, including, without limitation, the sourcing, structuring and negotiation of potential business acquisitions and customer contracts for the Company. Under the Management Agreement, the Company compensated Trinad LLC for its services by (i) paying a fee equal to $2,080,000, with $90,000 payable in advance of each consecutive 3-month calendar period during the term of the Management Agreement and with $1,000,000 due at the end of the 3-year term, and (ii) issuing a warrant to purchase 2,250,000 shares of the Company’s common stock at an exercise price of $0.075 per share (the “Warrant”). The Warrant may have been exercised in whole or in part by Trinad LLC at any time for a period of 10 years. On August 25, 2016, the Warrant was fully exercised on a cashless basis at an exercise price of $0.075 per share, resulting in the issuance 2,148,648 shares of the Company’s common stock. The total amount of $1,000,000 due to Trinad LLC was reflected as a liability on the accompanying March 31, 2016 balance sheet. Pursuant to the terms of the Management Agreement with Trinad Management, LLC, during March 2017, the Company paid $750,000 of the amount that was due at the end of the three-year term of the Management Agreement. The total amount due at March 31, 2017 was $239,080. The remaining amount was paid in April 2017. Trinad LLC continues to provide services to the Company at a fee of $30,000 per month on a month-to-month basis. For the years ended March 31, 2017 and 2016, the Company incurred $360,000 of such fees. Due to Related Parties As of March 31, 2017 and 2016, amounts due to related parties were $0 and $117,124, respectively, payable to Mr. Ellin, the Company’s Executive Chairman, President, director and majority stockholder. These amounts were provided to the Company for working capital as needed and are unsecured, non-interest bearing advances with no formal terms of repayment. Rent During the fiscal years ended March 31, 2017 and 2016, the Company subleased office space from Trinad LLC for no cost to the Company as part of our Management Agreement with Trinad LLC. Management estimates such amounts to be immaterial. The Company anticipates continuing to sublease such space at no cost to it for the foreseeable future. The Company believes that such property is in good condition and is suitable for the conduct of its business.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Mar. 31, 2017
Commitments and Contingencies [Abstract]
Commitments and Contingencies	Note 10 — Commitments and Contingencies Promotional Rights The Company acquires promotional rights from time to time that may contain obligations for future payments. During the year ended March 31, 2017, the Company incurred $350,000 in payment obligations for the acquisition of certain promotional rights. As of March 31, 2017, the Company is obligated under two licenses, production and/or distribution agreements to make guaranteed payments as follows: $500,000 for the fiscal year ended March 31, 2018, and $325,000 for the fiscal year ended March 31, 2019. The agreements also provide for a revenue share of 35-50% of capital and net revenues. In addition, there are two other agreements that provide for a revenue share of 50% on net revenues, but no guaranteed payments. If the events do not occur as planned and/or the Company does not undertake production of such events, or if the revenue from these events does not allow the Company to recover its production costs, no additional liability for additional payments or promotional right will remain. Legal Proceedings Bengough Settlement On May 20, 2016, Mr. Oliver Bengough, the Company’s former Chief Executive Officer and director, filed a Petition for Relief (the “Petition”) in the High Court of Justice, Chancery Division (the “Court”) against OCHL, OCL, KOKO UK and Mr. Ellin (collectively, the “Respondents”). In the Petition, Mr. Bengough claimed, among other things, certain breaches of duty by Mr. Ellin in connection with the corporate operations of the Respondents, as well as a “deterioration” of the relationship between the parties. OCHL was formed by OCL’s stockholders for the sole purpose of acquiring all of the registered and contributed capital of OCL, is a 50%-owned subsidiary of the Company and is the former parent of OCL. On September 22, 2016, Mr. Bengough entered into a Settlement Agreement (the “Settlement Agreement”) with the Respondents and Global Loan Agency Services Limited, as escrow agent (the “Escrow Agent”), relating to the Petition. Pursuant to the Settlement Agreement, the parties agreed, among other things, to (i) the terms of settlement in relation to all facts, matters and allegations raised by the Petition against the Respondents, including disputed liability under a junior promissory note, dated as of April 28, 2014, issued by OCHL and OCL in favor of JJAT, (ii) sell 48,878 ordinary shares and the 2,750 deferred ordinary shares in OCHL owned by the Company to Mr. Bengough on the terms provided in the Settlement Agreement, (iii) resolve certain ancillary matters arising from the past business dealings between Messrs. Ellin and Bengough, and (iv) to consummate the transactions contemplated thereunder and under certain related transaction documents (as defined below) (collectively, the “Settlement Transactions”). Pursuant to the terms of the Settlement Agreement, on November 24, 2016, Financial Consulting LLP BTG, an independent expert valuation firm engaged to determine the value of the ordinary shares in OCHL, delivered its final valuation report to the parties and that its analysis yielded that the value of the ordinary shares of OCHL is $4,455,833 (£3,612,057), therefore entitling the Company to $2,182,274 (£1,769,029) (or 50% of the value) minus $45,643 (£37,000) (as agreed to by the parties). On December 1, 2016, the Escrow Agent paid to the Company, via the funds deposited by Mr. Bengough, $2,182,274 as the Final Sale Price and the rest of Settlement Transactions were automatically consummated (including the Company’s sale of its OCHL shares to Mr. Bengough). Blink TV Limited and Northstar Media, Inc. On March 3, 2016, Blink TV Limited and Northstar Media, Inc. (collectively, the “Plaintiffs”) filed a claim in the Los Angeles County Superior Court of California against the Company and LiveXLive, alleging breaches of two different license agreements for the live-streaming rights to “Bestival,” an annual music festival which takes place on the Isle of Wight in England. LiveXLive and the Company demurred to the complaint on May 10, 2016, and, prior to the hearing on the demurrer, Plaintiffs amended their complaint. The amended complaint no longer states a claim against the Company and only states a single cause of action against LiveXLive for the alleged breach of a single license agreement. Plaintiffs are seeking $300,000 in damages. To date, LiveXLive has vigorously contested Plaintiffs’ claims. In doing so, LiveXLive filed a cross-complaint against Plaintiffs for breach of contract and breach of the implied covenant of good faith and fair dealing, on December 23, 2016. On May 11, 2017 the parties agreed to a mediation currently scheduled for June, 2017, and a trial date is set for March, 2018. We are currently not aware of any other pending legal proceedings. From time to time, we may become involved in various lawsuits and legal proceedings that arise in the ordinary course of business. An adverse result in these or other matters may have, individually or in the aggregate, a material adverse effect on our business, financial condition or operating results.

Equity Incentive Plan

Equity Incentive Plan	12 Months Ended
	Mar. 31, 2017
Equity Incentive Plan [Abstract]
Equity Incentive Plan	Note 11 — Equity Incentive Plan On August 29, 2016, the Company’s Board of Directors and stockholders approved the Company’s 2016 Equity Incentive Plan (the “2016 Plan”), which reserves a total of 22,800,000 shares of the Company’s common stock for issuance under the 2016 Plan. Incentive awards authorized under the 2016 Plan include, but are not limited to, incentive Internal Revenue Code of 1986, as amended. If an incentive award granted under the 2016 Plan expires, terminates, is unexercised or is forfeited, or if any shares are surrendered to the Company in connection with the exercise of an incentive award, the shares subject to such award and the surrendered shares will become available for further awards under the 2016 Plan. As of the date of the filing of this Annual Report, no stock options or any shares of common stock have been issued under the 2016 Plan.

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit)	12 Months Ended
	Mar. 31, 2017
Stockholders' Equity (Deficit)
Stockholders' Equity (Deficit)	Note 12 — Stockholders’ Equity (Deficit) Sale of Common Stock or Equity Units During the year ended March 31, 2017, the Company entered into securities purchase agreements with certain accredited investors, pursuant to which the Company sold an aggregate of 550,000 units at a purchase price of $2.50 per share for $1,375,000 in cash proceeds. Each unit consisted of one share of the Company’s common stock and a warrant to purchase 0.5 (one-half) share of the Company’s common stock, exercisable for a period of three years from the date of original issuance at exercise prices from $0.005 to $0.01 per share. During the year ended March 31, 2016, the Company entered into securities purchase agreements with accredited investors, pursuant to which the Company agreed to issue an aggregate of 762,500 units at a purchase price of $0.50-1.00 per unit for $612,500 in cash. Each unit consisted of one share of the Company’s common stock and one warrant to purchase a share of the Company’s common stock, exercisable for a period of four years from the date of original issuance at an exercise price of $0.005 per share. Issuance of Common Stock for Services During the year ended March 31, 2017, the Company issued 1,578,720 shares of its common stock valued at $2,279,589 to various consultants, including 100,000 shares to a related party valued at $167,000. The Company valued these shares at prices from $0.50 to $1.67 per share based on the most recent prices of the sale of our common stock near the date of grant. During the year ended March 31, 2016, the Company issued 1,802,000 shares of its common stock valued at $856,500 to various consultants and advisory board members. The Company valued these shares at prices from $0.25 - $0.50 per share based on the most recent prices of the sale of our common stock on the date of grant. Warrants On June 2, 2016, the Company issued warrants to acquire 205,920 shares of the Company’s common stock valued at $341,864 as an inducement to convert a convertible note. These warrants, along with 400,000 warrants issued to the noteholder upon issuance of the note, were exercised during the year ended March 31, 2017, at an exercise price of $0.005 per share, resulting in net proceeds to the Company of $3,030. In April, 2016, the Company issued warrants to Trinad Capital, a related party, to acquire 3,352,754 shares of the Company’s common stock valued at $1,661,114 at an exercise price of $0.005 to extend the maturity dates of the First and Second Senior Notes. These warrants were exercised during the year ended March 31, 2017, at an exercise price of $0.005 per share, resulting in net proceeds to the Company of $16,764. During the year ended March 31, 2017, the Company issued warrants to purchase aggregate 2,583,038 shares of the Company’s common stock along with various convertible notes. These warrants were valued at $676,518 at an exercise price of $0.01. During the year ended March 31, 2017, the Company issued warrants to purchase 275,000 shares of the Company’s common stock as part of securities purchase agreements. During the year ended March 31, 2017, warrants to purchase 9,665,360 shares of common stock were exercised, of which 2,250,000 warrants were exercised on a cashless basis, and the Company received proceeds of $48,123 related to the exercise of the balance of the warrants. During the year ended March 31, 2016, the Company issued 1,162,500 shares of the Company’s common stock upon exercise of 1,162,500 warrants at an exercise price of $0.005 per share, resulting in net proceeds to the Company of $5,813. The table below summarizes the Company’s warrant activities: Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Contractual Term Balance outstanding, April 1, 2016 3,600,000 $ 0.045 3.21 Granted 1,162,500 0.005 2.21 Exercised (1,162,500 ) 0.005 4.24 Forfeited/expired - - - Balance outstanding, March 31, 2016 3,600,000 0.050 4.16 Granted 6,416,712 0.007 2.91 Exercised (9,866,712 ) 0.022 3.15 Forfeited/expired - - - Balance outstanding, March 31, 2017 150,000 $ 0.010 2.99 Exercisable, March 31, 2017 150,000 $ 0.010 2.99 Increase of Authorized Common Stock and Creation of Preferred Stock On August 29, 2016, the Company’s Board of Directors and stockholders approved for the Company to file a Certificate of Amendment to its Articles of Incorporation (the “Certificate”) with the Secretary of State of the State of Nevada, which increased the Company’s authorized capital stock. The Certificate was filed and became effective on September 1, 2016. The Certificate increased the aggregate number of shares of capital stock which the Company has the authority to issue to 501,000,000 shares, consisting of 500,000,000 shares of common stock and 1,000,000 shares of the Company’s preferred stock, $0.001 par value per share (the “preferred stock”). The Company may issue shares of preferred stock from time to time in one or more series, each of which will have such distinctive designation or title as shall be determined by the Company’s Board of Directors and will have such voting powers, full or limited, or no voting powers, and such preferences and relative, participating, optional or other special rights and such qualifications, limitations or restrictions thereof, as shall be stated in the resolution or resolutions providing for the issue of such class or series of preferred stock as may be adopted from time to time by the Company’s Board of Directors. The Company’s Board of Directors will have the power to increase or decrease the number of shares of preferred stock of any series after the issuance of shares of that series, but not below the number of shares of such series then outstanding. In case the number of shares of any series shall be decreased, the shares constituting such decrease will resume the status of authorized but unissued shares of preferred stock. While the Company does not currently have any plans for the issuance of preferred stock, the issuance of such preferred stock could adversely affect the rights of the holders of common stock and, therefore, reduce the value of the common stock. It is not possible to state the actual effect of the issuance of any shares of preferred stock on the rights of holders of the common stock until and unless the Company’s Board of Directors determines the specific rights of the holders of the preferred stock; however, these effects may include: restricting dividends on the common stock, diluting the voting power of the common stock, impairing the liquidation rights of the common stock, or delaying or preventing a change in control of the Company without further action by the stockholders.

Income Tax Provision

Income Tax Provision	12 Months Ended
	Mar. 31, 2017
Income Tax Provision [Abstract]
Income Tax Provision	Note 13 — Income Tax Provision At March 31, 2017 and 2016, the Company had available federal and state net operating loss carryforwards to reduce future taxable income. The amounts available were approximately $15.4 million and $6.8 million for federal income tax purposes, respectively, and $15.4 million and $6.8 million for state income tax purposes respectively. The federal and state net operating loss carryforwards expire in 2037. Given the Company’s history of net operating losses, management has determined that it is more likely than not that the Company will not be able to realize the tax benefit of the carryforwards. Accordingly, the Company has not recognized a deferred tax asset for this benefit. The Company has adopted FASB guidelines that address the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under this guidance, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement. This guidance also provides guidance on derecognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. As of March 31, 2017 and 2016, the Company did not have a liability for unrecognized tax benefits, and no adjustment was required at adoption. The Company’s policy is to record interest and penalties on uncertain tax provisions as income tax expense. As of March 31, 2017 and 2016, the Company has not accrued interest or penalties related to uncertain tax positions. Additionally, tax years 2014 through 2016 remain open to examination by the major taxing jurisdictions to which the Company is subject. Upon the attainment of taxable income by the Company, management will assess the likelihood of realizing the tax benefit associated with the use of the carryforwards and will recognize the appropriate deferred tax asset at that time. Significant components of the Company’s deferred income tax assets are as follows as of: 2017 2016 Net operating loss carryforward $ 6,152,000 $ 2,708,000 Stock-based compensation 912,000 343,000 Impairment of note receivable 85,000 - Loss on sale of investment in OCHL 1,116,000 - Equity in earnings of OCHL (53,000 ) (164,000 ) Total deferred tax assets 8,212,000 2,887,000 Valuation allowance (8,212,000 ) (2,887,000 ) Net deferred tax asset $ - $ - Reconciliation of the effective income tax rate to the U.S. statutory rate is as follows: 2017 2016 U.S federal statutory income tax -34.00 % -34.00 % State tax, net of federal tax benefit -5.80 % -5.80 % Permanent differences -65.52 % - % Change in valuation allowance 105.32 % 39.80 % Effective tax rate 0.00 % 0.00 %

Subsequent Events

Subsequent Events	12 Months Ended
	Mar. 31, 2017
Subsequent Events [Abstract]
Subsequent Events	Note 14 — Subsequent Events Unsecured Convertible Notes Payable Subsequent to the period ended March 31, 2017 the Company issued eight, 6% unsecured note payables to investors for total cash principal of $1,595,000. These notes are due between April 2018 and May 2018. The noteholders shall in their sole discretion have the option to convert all outstanding principal and interest into the Company’s Common Stock before the maturity date at a conversion price per share based upon the Company’s current valuation, as determined by our board of directors. If the Company raises a minimum of $5,000,000 (excluding the amount converting pursuant to the note) of aggregate gross proceeds from an equity financing in one or more closings prior to the maturity date, the noteholders will have the right to convert all outstanding note principal and interest into the same equity securities issued in such equity financing at 75% of the issuance price of the securities issued in such financing. In addition, the noteholders received warrants to purchase an aggregate of 797,500 shares of the Company’s common stock at an exercise price of $0.01 per share with a relative fair value of $723,533. As of the issuance dates of these notes, the effective conversion price was $0.91, and the market price of the shares on the date of conversion was approximately $1.67 per share. As such, the Company expects to recognize a beneficial conversion feature of $723,533. As a result, the Company expects to record a note discount of $1,447,066 to account for the relative fair value of the warrants and the notes’ beneficial conversion features which will be amortized as interest expense over the term of the notes. Employment Agreements In April and May 2017, the Company entered into employment agreements with two officers for a term of two years at an annual salary of $120,000 and $180,000 respectively. In addition, one of the officers was granted 300,000 shares of the Company’s common stock valued at $501,000 that will vest in equal tranches over the 24-month term of the employment agreement. The officer will also receive a bonus of $100,000 upon the closing of an underwritten public offering of the Company’s common stock. The other officer was granted 400,000 shares of the Company’s common stock valued at $668,000 that will vest in increments, with the first tranche of 200,000 shares vesting 12 months from the effective date and the remaining number of shares vesting monthly thereafter, with 100% vesting over the 24-month term of the employment agreement. Wantickets Acquisition On May 5, 2017, LiveXLive Tickets, Inc., (“LXL Tickets”) a wholly owned subsidiary of the Company, entered into an Asset Purchase Agreement (“APA”) with Wantickets and certain other parties, whereby the Company purchased certain operating assets of Wantickets for total consideration of 2,000,000 shares of common stock of the Company valued at $3,340,000 ($1.67 per share) and the assumption of certain liabilities of Wantickets. The Company is in the process of completing the allocation of the purchase price to the assets and liabilities acquired. In connection with the transaction, LXL Tickets entered into employment agreements with key employees of Wantickets for a term of two years each. One officer, Joe Schnaier, the Chief Executive Officer of Wantickets, will receive an annual salary of $220,000 and a bonus of 2,000,000 shares of common stock if LXL Tickets earns net income of $3 million in the twelve months following the effective date of his employment agreement or net income of $4 million in the twelve months thereafter. The other officer will receive an annual salary of $160,000 and receive a number of shares of the Company’s common stock equal to $15,000 each year. In addition, pursuant to the APA and the Letter Agreement, dated as of May 5, 2017 (the “Letter Agreement”), entered into among the Company, LXL Tickets and Mr. Schnaier, the parties agreed that, commencing May 5, 2017, Mr. Schnaier will promptly pay for all of LXL Tickets’ net losses of its business for each calendar month (or pro rata thereof), up to a total of $100,000 per month, and for any liabilities exceeding $100,000 in the aggregate that arose from April 1, 2017 to May 5, 2017 (inclusive), until the earlier of (x) such time as a public offering is consummated or (b) May 5, 2018 (such earlier date as between clause (x) and (y), the “Funding End Date”), and that any salaries or other payments or amounts due to under the employment agreements described above shall be included in the calculation of the net loss for the applicable period (collectively, the “JS Payment Obligation”). Pursuant to the Letter Agreement, the parties further agreed that all payments made by Mr. Schnaier as part of the JS Payment Obligation shall be deemed to be a loan by Mr. Schnaier to LXL Tickets (the “Loaned Funds”), and that the Company and LXL Tickets shall repay to Mr. Schnaier the total amount of the Loaned Funds within five business days after the Funding End Date; provided that the Company and LXL Tickets may prepay or repay in full the Loaned Funds at any time prior to the Funding End Date without any penalty. An unaudited pro forma balance sheet as of March 31, 2017 as if the acquisition had occurred as of that date is as follows: March 31, 2017 (unaudited) Current Assets Cash and cash equivalents $ 1,477,229 Prepaid expense 21,569 Total Current Assets 1,498,798 Other Assets Property and equipment, net 175,407 Intangibles 3,222,000 Total Assets $ 4,896,205 Liabilities and Stockholders’ Deficit Current Liabilities: Accounts payable and accrued liabilities $ 542,035 Note payable 277,270 Note payable, shareholder 3,603,446 Current portion of unsecured convertible notes, net of discount 67,858 Services payable, related party 239,080 Total Current Liabilities 4,729,689 Unsecured convertible notes - related party, net of discount 11,668 Unsecured convertible notes, net of discount and current portion 220,540 Total Liabilities 4,961,897 Stockholders’ Deficit: Preferred stock, $0.001 par value; 1,000,000 shares authorized; no shares issued or — Common stock, $0.001 par value; 500,000,000 shares authorized; 105,996,974 shares issued and outstanding. 105,997 Additional paid in capital 27,924,201 Accumulated deficit (28,095,890 ) Total stockholders’ deficit (65,692 ) Total Liabilities and Stockholders’ Deficit $ 4,896,205 Unaudited pro forma results of operations for the years ended March 31, 2017 and 2016 as if the acquisition has occurred as of the earliest dates presented are as follows: For the Year Ended March 31, 2017 For the Year Ended March 31, 2016 (unaudited) (unaudited) Revenue $ 3,972,000 $ 5,744,000 Cost of revenue 1,147,000 2,052,000 Gross profit 2,825,000 3,692,000 Operating expenses: Selling, general and administrative 9,479,801 7,297,000 Related party expenses 360,000 360,000 Total operating expenses 9,839,801 7,657,000 Loss from operations (7,014,801 ) (3,965,000 ) Other income (expense) Interest expense, net (497,152 ) (218,498 ) Other income 6,667 — Fair value of warrants issued for note extension and inducement to convert (2,002,977 ) — Earnings from investment in OCHL 132,832 410,553 Fair value of warrants and beneficial conversion feature on debt conversion (3,248,948 ) — Fair value of beneficial conversion feature (136,936 ) — Impairment of note receivable - related party (213,331 ) — Loss on sale of investment in OCHL (2,790,073 ) — Total other income (expense) (8,749,918 ) 192,055 Net loss $ (15,764,719 ) $ (3,772,945 ) Net Loss per common share – basic and diluted $ (0.16 ) $ (0.04 ) Weighted average common shares – basic and diluted 99,596,206 92,082,796 Promotional Rights Subsequent to March 31, 2017, the Company entered into license, production and/or distribution agreements to make guaranteed payments as follows: $210,000 for the fiscal year ended March 31, 2018, $190,000 for the fiscal year ended March 31, 2019, and $25,000 for the year ended March 31, 2020. One of the agreements also provides for a revenue share of 50% of net revenues. If the events do not occur as planned and/or the Company does not undertake production of such events, or if the revenue from these events does not allow the Company to recover its production costs, no additional liability for additional payments or promotional right will remain. Equity Issuances Subsequent to March 31, 2017, the Company issued an aggregate of 947,500 shares of its common stock to investors in consideration of an aggregate of $9,475 as a result of the exercise of 947,500 warrants at an exercise price of $0.01 per share. Subsequent to March 31, 2017, the Company issued an aggregate of 737,500 shares of its common stock valued at $1.67 per share as fees to our employees, directors, advisors and consultants.

Significant Accounting Polici21

Significant Accounting Policies and Practices (Policies)	12 Months Ended
	Mar. 31, 2017
Significant Accounting Policies and Practices [Abstract]
Revenue Recognition Policy	Revenue Recognition Policy The Company recognizes revenue from its live events and show productions when all of the following criteria are met: (i) persuasive evidence of an arrangement exists, (ii) the show or live event has been completed and occurred and there are no future production obligations, (iii) the sales price is fixed or determinable, and (iv) collectability is reasonably assured.
Use of Estimates and Assumptions	Use of Estimates and Assumptions The preparation of financial statements in conformity with generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date(s) of the financial statements and the reported amounts of revenues and expenses during the reporting period(s). Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Management regularly evaluates the key factors and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates. Significant estimates include those related to assumptions used in impairment testing of long term assets, accruals for potential liabilities, assumptions made in valuing equity instruments issued for services and issued with convertible notes, and recognition of deferred tax assets. Actual results could differ from those estimates.
Principles of Consolidation	Principles of Consolidation The Company’s consolidated subsidiaries and/or entities are as follows: Name of consolidated subsidiary or entity State or other Date of Attributable LiveXLive Tickets, Inc. Delaware April 24, 2017 100% LXL Studios, Inc. Delaware July 15, 2016 100% LiveXLive, Corp. Delaware February 24, 2015 100% KOKO (Camden) Holdings (US), Inc. Delaware March 17, 2014 100% KOKO (Camden) UK Limited England and Wales November 7, 2013 100% The Company’s consolidated financial statements include all accounts of the Company and its consolidated subsidiaries and/or entities as of reporting period ending date(s) and for the reporting period(s) then ended, except for LiveXLive Tickets, Inc., as it was formed after March 31, 2017. All inter-Company balances and transactions have been eliminated.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company follows the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) for disclosures about fair value of its financial instruments and to measure the fair value of its financial instruments. The FASB ASC establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The three levels of fair value hierarchy are described below: Level 1 Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. Level 2 Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3 Pricing inputs that are generally observable inputs and not corroborated by market data. Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable. The carrying amounts of the Company’s financial assets and liabilities, including cash, prepaid expenses, accounts payable, accrued expenses, and other current liabilities, approximate their fair values because of the short maturity of these instruments. The fair value of notes payable and convertible notes approximate their fair values since the current interest rates and terms on these obligations are the same as prevailing market rates.
Investment in Unconsolidated Subsidiary Under the Equity Method	Investment in Unconsolidated Subsidiary Under the Equity Method The Company accounts for investments in which the Company owns more than 20% of the investee using the equity method in accordance with ASC Topic 323, Investments — Equity Method and Joint Ventures
Stock-Based Compensation	Stock-Based Compensation The Company periodically issues stock warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock warrant grants issued and vesting to employees based on the authoritative guidance provided by FASB where the value of the award is measured on the date of grant and recognized as compensation expense on the straight-line basis over the vesting period. The Company accounts for stock warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the FASB where the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. In certain circumstances where there are no future performance requirements by the non-employee, warrants grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date. The fair value of the Company's stock warrant grants are estimated using the Black-Scholes-Merton Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or warrants, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model, and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods. In light of the very limited trading of the our common stock, market value of the shares issued was determined based on the then most recent price per share at which we sold common stock in a private placement during the periods then ended.
Income Taxes	Income Taxes The Company follows the asset and liability method which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are based on the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the Statements of Operations in the period that includes the enactment date.
Loss Per Share	Loss Per Share Basic loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted loss per share reflects the potential dilution, using the treasury stock method that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the loss of the Company. In computing diluted loss per share, the treasury stock method assumes that outstanding options and warrants are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. At March 31, 2017 and 2016, the Company had 150,000 and 3,600,000 warrants outstanding, respectively, and 3,028,325 and 410,260 shares issuable for our convertible note payables, respectively, which were excluded from the loss per share calculation, as they were anti-dilutive.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In May 2014, the FASB issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers In February 2016, the FASB issued ASU No. 2016-02, Leases Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the SEC did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statement presentation or disclosures.

Significant Accounting Polici22

Significant Accounting Policies and Practices (Tables)	12 Months Ended
	Mar. 31, 2017
Significant Accounting Policies and Practices [Abstract]
Schedule of consolidated subsidiaries and/or entities	Name of consolidated subsidiary or entity State or other Date of Attributable LiveXLive Tickets, Inc. Delaware April 24, 2017 100% LXL Studios, Inc. Delaware July 15, 2016 100% LiveXLive, Corp. Delaware February 24, 2015 100% KOKO (Camden) Holdings (US), Inc. Delaware March 17, 2014 100% KOKO (Camden) UK Limited England and Wales November 7, 2013 100%

Equity Investment in OCHL (Tabl

Equity Investment in OCHL (Tables)	12 Months Ended
	Mar. 31, 2017
Equity Investments in OCHL [Abstract]
Schedule of change in investment in affiliate	Balance as of March 31, 2015 $ 4,478,962 50% share of net income for the period 410,553 Balance as of March 31, 2016 4,889,515 50% share of net income for the period 132,832 Balance as of November 24, 2016 5,022,347 Proceeds received (2,182,274 ) Liability extinguished (50,000 ) Loss recognized $ 2,790,073
Schedule of net income from OCHL	Period from April 1, November 24, 2016 Fiscal Year Ended Revenue $ 3,921,204 $ 6,754,707 Cost of revenue 546,480 920,667 Gross profit 3,374,724 5,834,040 Operating expenses Selling, general and administrative 2,893,306 4,613,058 Depreciation and amortization 74,828 133,106 Total operating expenses 2,968,134 4,746,164 Income from operations before other expenses 406,590 1,087,876 Other expenses Interest 28,002 45,997 Income before provision for taxes 378,588 1,041,879 Taxes 112,924 220,773 Net income $ 265,664 $ 821,105
Schedule of carrying amounts of major classes of assets and liabilities of OCHL	March 31, Assets Current assets Cash and cash equivalents $ 386,009 Accounts receivable 24,743 Inventory 62,548 Prepaid expenses and other current assets 533,128 Total current assets 1,006,429 Other assets Property and equipment, net of accumulated depreciation 867,975 Total assets $ 1,874,205 Liabilities and Shareholders’ Deficit Current liabilities Accounts payable $ 514,488 Taxes payable 410,504 Notes payable, current 207,978 Other accrued liabilities 460,290 Total current liabilities 1,593,210 Deferred rent – noncurrent 937,459 Total liabilities 2,530,669 Shareholders deficit (656,464 ) Total Liabilities and Shareholders’ Deficit $ 1,874,205

Property and Equipment (Tables)

Property and Equipment (Tables)	12 Months Ended
	Mar. 31, 2017
Property and Equipment [Abstract]
Schedule of property plant and equipment	March 31, March 31, Production equipment $ 51,304 $ 51,304 Computer equipment 42,078 23,125 Total property and equipment 93,382 74,429 Accumulated depreciation (35,975 ) (11,860 ) Property and equipment, net $ 57,407 $ 62,569

Notes Payable to Major Stockh25

Notes Payable to Major Stockholder (Tables)	12 Months Ended
	Mar. 31, 2017
Notes Payable to Major Stockholder [Abstract]
Schedule of outstanding notes payable	March 31, March 31, (A) First Senior Note $ - $ 1,000,000 (B) Second Senior Note - 1,784,000 (C) 6% Unsecured Convertible Note 3,603,446 - Total $ 3,603,446 $ 2,784,000 (A) First Senior Note — Trinad Capital Master Fund On December 31, 2014, the Company entered into a senior convertible promissory note (the “First Senior Note”) with Trinad Capital allowing for advances up to a maximum loan amount of $1,000,000, plus interest at the rate of 6% per annum on the unpaid principal amount of outstanding advances. At the time the First Senior Note was made, Trinad Capital advanced $700,000 to the Company and had accrued $70,151 in unpaid interest. Pursuant to the terms of the Senior Note, all outstanding unpaid principal and accrued interest was originally due and payable on June 30, 2016 or such later date as Trinad Capital may agree to in writing unless, prior to such date, the First Senior Note has been repaid in full or Trinad Capital elects to convert all or any portion of the then-outstanding loan balance into common stock of the Company in connection with the Company consummating an equity financing in excess of $5,000,000 or greater as set forth in the terms of the First Senior Note. Subsequent to the making of the First Senior Note: ● On January 27, 2015, the Company and Trinad Capital entered into an amendment to the First Senior Note, effective as of December 31, 2014, pursuant to which: (1) the term of the First Senior Note was extended to June 30, 2016 and (2) the conversion price for conversion of the unpaid balance and interest outstanding in connection with an equity financing was amended to be the price per share equal to the average price per share paid by investors in such equity financing; ● On February 5, 2015, the Company and Trinad Capital amended and restated the First Senior Note, effective as of December 31, 2014, to eliminate the convertibility feature of the note was eliminated in its entirety; and ● On April 21, 2016, the First Senior Note was further amended to extend its maturity date to June 30, 2017, or such later date as Trinad Capital may agree to in writing. For extending the due date of the First Senior Note to June 30, 2017, the Company issued to Trinad Capital warrants to purchase 1,144,986 shares of its common stock, with an exercise price of $0.005 per share and expiration date of April 21, 2020. During the fiscal year ended March 31, 2017, these warrants were fully exercised. The aggregate fair value of the 1,144,986 warrants were valued at $567,282 using the Black-Scholes-Merton Option Pricing model with the following average assumptions: risk-free interest rate of 1.30%; dividend yield of 0%; volatility rate of 100%; and an expected life of four years (statutory term). The maturity date extension was considered to be a debt restructuring that is accounted for as a debt extinguishment. Therefore, the value of the warrants was expensed as of April 21, 2016. As of March 31, 2016, $1,000,000 of principal was outstanding under the First Senior Note and accrued interest $140,555 is reflected on the consolidated balance sheet as accrued interest payable, related party as of March 31, 2016. On February 21, 2017, aggregate principal and accrued interest of $1,197,897 due under this note was exchanged into a convertible note discussed below (C). (B) Second Senior Note — Trinad Capital Master Fund On April 8, 2015, the Company entered into a second senior promissory note (the “Second Senior Note”) with Trinad Capital in the amount of $195,500. The Second Senior Note bears interest at the rate of eight percent (8%) per annum and all outstanding unpaid principal and accrued interest is due and payable on June 30, 2016 or such later date as Trinad Capital may agree to in writing, unless prior to such date this note has been prepaid in full. During the year ended March 31, 2016, Trinad Capital made advances to the Company totaling $1,784,000. Subsequent to the making of the Second Senior Note: ● On July 10, 2015, the Second Senior Note was amended and restated to increase the principal amount from $195,500 to the lesser of (i) $1,000,000 (the “Maximum Advance Amount”), or (ii) the aggregate unpaid principal amount of the advances; ● On November 23, 2015, Second Senior Note was amended the Second Senior Note to increase the Maximum Advance Amount to $2,000,000; and ● On April 26, 2016, the Second Senior Note was amended to increase the Maximum Advance Amount to $3,000,000 and to extend the maturity date to June 30, 2017 or such later date as Trinad Capital may agree to in writing. For extending the due date of the Second Senior Note to June 30, 2017, the Company issued to Trinad Capital warrants to purchase 2,207,768 shares of its common stock, with an exercise price of $0.005 per share and expiration date of April 21, 2020. During the fiscal year ended March 31, 2017, these warrants were fully exercised. The aggregate fair value of the 2,207,768 warrants issued upon extension of the note were valued at $1,093,832 using the Black-Scholes-Merton Option Pricing model with the following average assumptions: risk-free interest rate of 1.30%; dividend yield of 0%; volatility rate of 100%; and an expected life of four years (statutory term). The maturity date extension was considered to be a debt restructuring that is accounted for as a debt extinguishment. Therefore, the value of the warrants was expensed as of April 21, 2016. The amount due to Trinad Capital under the Second Senior Note was $1,784,000 at March 31, 2016. During the year ended March 31, 2017, Trinad Capital made additional advances to the Company under the Second Senior Note totaling $820,100. The Company also made repayments of the Second Senior Note totaling $450,000 during year ended March 31, 2017. As of February 21, 2016, $2,154,100 of principal was outstanding under the Second Senior Note. Accrued interest of $87,048 is reflected on the balance sheet as accrued interest payable, related party as of March 31, 2016. On February 21, 2017, aggregate principal and accrued interest of $2,383,180 due under this note was exchanged into a convertible note discussed below (C). (C) 6% Unsecured Convertible Note — Trinad Capital Master Fund On February 21, 2017, the Company issued a 6% unsecured convertible note payable to Trinad Capital to convert aggregate principal and interest of $3,581,077 under the First and Second Senior Notes with Trinad Capital discussed above. This convertible note is due on March 31, 2018. Before its maturity, the noteholder shall in its sole discretion have the option to convert all outstanding principal and interest into the Company’s common stock at a conversion price per share based upon the Company’s current valuation, as determined by the Board of Directors. If the Company raises a minimum of $5,000,000 (excluding the amount converting pursuant to the note) of aggregate gross proceeds from an equity financing in one or more closings prior to the maturity date, Trinad Capital will have the right to convert all outstanding note principal and interest into the same equity securities issued in such equity financing at 75% of the issuance price of the securities issued in such financing. In addition, Trinad Capital received 1,790,539 warrants to purchase shares of the Company’s common stock at an exercise price of $0.01 per share. The warrants were exercised on February 28, 2017. The conversion of the First and Second Senior Notes into an unsecured convertible note and warrants was considered to be a debt restructuring that is accounted for as a debt extinguishment. The aggregate relative fair value of the 1,790,539 warrants issued to the noteholder was determined to be $1,624,474 using the Black-Scholes-Merton Option Pricing model with the following average assumptions: risk-free interest rate of 1.50%; dividend yield of 0%; volatility rate of 100%; and an expected life of three years (statutory term). As of February 21, 2016, the effective conversion price was $0.91, and the market price of the shares on the date of conversion was approximately $1.67 per share. As such, the Company recognized a beneficial conversion feature of $1,624,474. The relative fair value of the warrants and the note’s beneficial conversion feature totaling $3,248,948 was expensed as of March 31, 2017. At March 31, 2017, the balance of the note and accrued interest were $3,581,077 and $22,369, respectively.

Related Party Unsecured Conve26

Related Party Unsecured Convertible Notes Payable (Tables)	12 Months Ended
	Mar. 31, 2017
Related Party Unsecured Convertible Notes Payable [Abstract]
Summary of related party unsecured convertible notes payable	(A) 6% Unsecured Convertible Note – due September 13, 2018 $ - $ - (B) 6% Unsecured Convertible Note – due on March 31, 2018 50,707 - Less accumulated amortization of Valuation Discount (39,039 ) - Net $ 11,668 $ - (A) Convertible Note — JJAT On August 19, 2016, the Company issued a 6% unsecured convertible note payable to a related party for total principal amount of $55,000. This note was due on September 30, 2018. Before its maturity, the noteholder had in its sole discretion have the option to convert all outstanding principal and interest into the Company’s common stock at a conversion price per share based upon the Company’s current valuation, as determined by the Board of Directors. If the Company raises a minimum of $5,000,000 (excluding the amount converting pursuant to the note) in the aggregate in gross proceeds from an equity financing led by a reputable institutional investor in one or more closings prior to the maturity date, the noteholder will have the right to convert all outstanding principal and interest into the same equity securities issued in such qualified equity financing at 75% of the issuance price of the securities in such financing. On December 21, 2016, this note was repaid. (B) Convertible Note — Marvin Ellin On January 4, 2017, the Company issued a 6% unsecured convertible note payable to a certain investor for total principal amount of $50,000. This note will be due on September 13, 2018. Before its maturity, the noteholder shall in its sole discretion have the option to convert all outstanding principal and interest into the Company’s common stock at a conversion price per share based upon the Company’s current valuation, as determined by the Board of Directors. If the Company raises a minimum of $5,000,000 (excluding the amount converting pursuant to the note) of aggregate gross proceeds from an equity financing in one or more closings prior to the maturity date, the noteholder will have the right to convert all outstanding note principal and interest into the same equity securities issued in such equity financing at 75% of the issuance price of the securities issued in such financing. In addition, the noteholder received 25,000 warrants to purchase shares of the Company’s common stock at an exercise price of $0.01 per share. The aggregate relative fair value of the 25,000 warrants issued to the investor was determined to be $22,681 using the Black-Scholes-Merton Option Pricing model with the following average assumptions: risk-free interest rate of 1.50%; dividend yield of 0%; volatility rate of 100%; and an expected life of three years (statutory term). As of February 21, 2017, the effective conversion price was $0.91, and the market price of the shares on the date of conversion was approximately $1.67 per share. As such, the Company recognized a beneficial conversion feature of $22,681. The aggregate value of the warrants and beneficial conversion feature of $45,362 was considered as debt discount upon issuance and will be amortized as interest over the term of the note or in full upon the conversion of the note. During year ended March 31, 2017, the Company amortized $6,323 of such discount to interest expense, and the unamortized discount as of March 31, 2017 was $39,039. As of March 31, 2017, $50,000 of principal and $707 of accrued interest was due under the note.

Unsecured Convertible Notes P27

Unsecured Convertible Notes Payable (Tables)	12 Months Ended
	Mar. 31, 2017
Unsecured Convertible Notes Payable [Abstract]
Schedule of unsecured convertible notes payable	March 31, March 31, (A) 8% Unsecured Convertible Notes – Due on January 19, 2018 $ — $ 200,000 (B) 6% Unsecured Convertible Notes – Due on September 13, 2018 154,882 — (C) 6% Unsecured Convertible Notes – Due between January 31, 2018 and September 30, 2018 1,248,267 — Total 1,403,149 200,000 Less accumulated amortization of Valuation Discount (1,114,751 ) (89,727 ) Net 288,398 110,273 Less note payable, current 67,858 — Notes payable, long-term $ 220,540 $ 100,273 (A) On January 19, 2016, the Company issued three 8% unsecured convertible notes payable to investors (the “Lenders”) for an aggregate amount of $200,000. These notes were due on January 19, 2018. Before the maturity date, the noteholder had in its sole discretion have the option to convert all outstanding principal and interest into the Company’s common stock at a conversion price per share based upon the Company’s current valuation, as determined by the Board of Directors. If the Company raises a minimum of $2,500,000 (excluding the amount converting pursuant to the notes) in the aggregate in gross proceeds from an equity financing led by a reputable institutional investor in one or more closings prior to the maturity date, the Lenders will have the right to convert all outstanding principal and interest into the same equity securities issued in such qualified equity financing at 75% of the issuance price of the securities in such financing. In addition, the Lenders received 400,000 warrants to purchase shares of the Company’s common stock at an exercise price of $0.005 per share. The warrants were exercised during the year ended March 31, 2017. The aggregate relative fair value of the 400,000 warrants issued to the Lender was determined to be $99,915 using the Black-Scholes-Merton Option Pricing model with the following average assumptions: risk-free interest rate of 1.30%; dividend yield of 0%; volatility rate of 100%; and an expected life of four years (statutory term). The value of the warrants of $99,915 was considered as debt discount upon issuance and was being amortized as interest over the term of the notes or in full upon the conversion of the corresponding notes. During the year ended March 31, 2016, the Company amortized $9,818 of such discount to interest expense, and the unamortized discount as of March 31, 2016 was $89,727. On June 6, 2016, the Lenders converted $200,000 of principal and $5,918 of interest into 205,918 shares of the Company’s common stock at a conversion price of $1 per share. As the market price of the shares on the date of conversion was approximately $1.67 per share, the Company recognized a beneficial conversion cost of $136,936. As a result of the conversion, the remaining debt discount of $89,727 was fully amortized to interest expense as of the date of conversion. As an inducement for the conversion, the Lenders were issued 205,920 warrants to purchase shares of the Company’s common stock at an exercise price of $0.005 per share. The aggregate fair value of the 205,920 warrants issued to the Lenders was $341,864 using the Black-Scholes-Merton Option Pricing model with the following average assumptions: risk-free interest rate of 1.20%; dividend yield of 0%; volatility rate of 100%; and an expected life of three years (statutory term). The value of the warrants of $341,864 was considered as additional interest expense upon their issuance. The warrants were exercised immediately into 205,920 shares of the Company’s common stock with net proceeds of $1,030 to the Company. (B) On September 14, 2016, the Company issued a 6% unsecured convertible note payable to a certain investor for total principal amount of $150,000. This note will be due on September 13, 2018. Before the maturity date, the noteholder shall in its sole discretion have the option to convert all outstanding principal and interest into the Company’s common stock at a conversion price per share based upon the Company’s current valuation, as determined by the Board of Directors. If the Company raises a minimum of $5,000,000 (excluding the amount converting pursuant to the note) of aggregate gross proceeds from an equity financing in one or more closings prior to the maturity date, the noteholder will have the right to convert all outstanding note principal and interest into the same equity securities issued in such equity financing at 75% of the issuance price of the securities issued in such financing. In addition, the noteholder received 150,000 warrants to purchase shares of the Company’s common stock at an exercise price of $0.005 per share. The aggregate relative fair value of the 150,000 warrants issued to the noteholder was determined to be $93,612 using the Black-Scholes-Merton Option Pricing model with the following average assumptions: risk-free interest rate of 0.90%; dividend yield of 0%; volatility rate of 100%; and an expected life of three years (statutory term). As of September 14, 2016, the effective conversion price was $0.63, and the market price of the shares on the date of conversion was approximately $1.67 per share. As such, the Company recognized a beneficial conversion feature of $56,388. As a result, the Company recorded a note discount of $150,000 to account for the relative fair value of the warrants and the notes’ beneficial conversion feature which will be amortized as interest over the term of the note. During year ended March 31, 2017, the Company amortized $40,741 of such discount to interest expense, and the unamortized discount as of March 31, 2017 was $109,259. As of March 31, 2017, $4,882 accrued interest was added to principal balance. (C) Between November 22, 2016 and March 27, 2017, the Company issued seven 6% unsecured convertible notes payable to certain investors for aggregate total principal of $1,235,000. The notes are due on various dates through September 30, 2018. Before the maturity date, the noteholders shall in their sole discretion have the option to convert all outstanding principal and interest into the Company’s common stock at a conversion price per share based upon the Company’s current valuation, as determined by the Board of Directors. If the Company raises a minimum of $5,000,000 (excluding the amount converting pursuant to the note) of aggregate gross proceeds from an equity financing in one or more closings prior to the maturity date, the noteholders will have the right to convert all outstanding note principal and interest into the same equity securities issued in such equity financing at 75% of the issuance price of the securities issued in such financing. In addition, the noteholders received an aggregate of 617,500 warrants to purchase shares of the Company’s common stock at an exercise price of $0.01 per share. The aggregate relative fair value of the 617,500 warrants issued to the noteholders was determined to be $560,226 using the Black-Scholes-Merton Option Pricing model with the following average assumptions: risk-free interest rate of 1.35-1.53%; dividend yield of 0%; volatility rate of 100%; and an expected life of three years (statutory term). At the issuance of these notes, the effective conversion price was $0.91 and the market price of the shares on the date of conversion was approximately $1.67 per share, the Company recognized aggregate beneficial conversion features of $560,226. As a result, the Company recorded a note discount of $1,120,450 to account for the relative fair values of the warrants and the notes’ beneficial conversion features which will be amortized as interest over the terms of the notes or in full upon conversion of the notes. During year ended March 31, 2017, the Company amortized $114,961 of such discount to interest expense, and the unamortized discount as of March 31, 2017 was $1,004,590.

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit) (Tables)	12 Months Ended
	Mar. 31, 2017
Stockholders' Equity (Deficit) [Abstract]
Schedule of warrant activities	Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Contractual Term Balance outstanding, April 1, 2016 3,600,000 $ 0.045 3.21 Granted 1,162,500 0.005 2.21 Exercised (1,162,500 ) 0.005 4.24 Forfeited/expired - - - Balance outstanding, March 31, 2016 3,600,000 0.050 4.16 Granted 6,416,712 0.007 2.91 Exercised (9,866,712 ) 0.022 3.15 Forfeited/expired - - - Balance outstanding, March 31, 2017 150,000 $ 0.010 2.99 Exercisable, March 31, 2017 150,000 $ 0.010 2.99

Income Tax Provision (Tables)

Income Tax Provision (Tables)	12 Months Ended
	Mar. 31, 2017
Income Tax Provision [Abstract]
Schedule of significant components of the company's deferred income tax assets	2017 2016 Net operating loss carryforward $ 6,152,000 $ 2,708,000 Stock-based compensation 912,000 343,000 Impairment of note receivable 85,000 - Loss on sale of investment in OCHL 1,116,000 - Equity in earnings of OCHL (53,000 ) (164,000 ) Total deferred tax assets 8,212,000 2,887,000 Valuation allowance (8,212,000 ) (2,887,000 ) Net deferred tax asset $ - $ -
Schedule of reconciliation of the effective income tax rate	2017 2016 U.S federal statutory income tax -34.00 % -34.00 % State tax, net of federal tax benefit -5.80 % -5.80 % Permanent differences -65.52 % - % Change in valuation allowance 105.32 % 39.80 % Effective tax rate 0.00 % 0.00 %

Subsequent Events (Tables)

Subsequent Events (Tables)	12 Months Ended
	Mar. 31, 2017
Subsequent Events [Abstract]
Schedule of unaudited pro forma balance sheet	March 31, 2017 (unaudited) Current Assets Cash and cash equivalents $ 1,477,229 Prepaid expense 21,569 Total Current Assets 1,498,798 Other Assets Property and equipment, net 175,407 Intangibles 3,222,000 Total Assets $ 4,896,205 Liabilities and Stockholders’ Deficit Current Liabilities: Accounts payable and accrued liabilities $ 542,035 Note payable 277,270 Note payable, shareholder 3,603,446 Current portion of unsecured convertible notes, net of discount 67,858 Services payable, related party 239,080 Total Current Liabilities 4,729,689 Unsecured convertible notes - related party, net of discount 11,668 Unsecured convertible notes, net of discount and current portion 220,540 Total Liabilities 4,961,897 Stockholders’ Deficit: Preferred stock, $0.001 par value; 1,000,000 shares authorized; no shares issued or outstanding - Common stock, $0.001 par value; 500,000,000 shares authorized; 105,996,974 shares issued and outstanding. 105,997 Additional paid in capital 27,924,201 Accumulated deficit (28,095,890 ) Total stockholders' deficit (65,692 ) Total Liabilities and Stockholders’ Deficit $ 4,896,205
Schedule of unaudited pro forma results of operations	For the Year Ended March 31, 2017 For the Year Ended March 31, 2016 (unaudited) (unaudited) Revenue $ 3,972,000 $ 5,744,000 Cost of revenue 1,147,000 2,052,000 Gross profit 2,825,000 3,692,000 Operating expenses: Selling, general and administrative 9,479,801 7,297,000 Related party expenses 360,000 360,000 Total operating expenses 9,839,801 7,657,000 Loss from operations (7,014,801 ) (3,965,000 ) Other income (expense) Interest expense, net (497,152 ) (218,498 ) Other income 6,667 — Fair value of warrants issued for note extension and inducement to convert (2,002,977 ) — Earnings from investment in OCHL 132,832 410,553 Fair value of warrants and beneficial conversion feature on debt conversion (3,248,948 ) — Fair value of beneficial conversion feature (136,936 ) — Impairment of note receivable - related party (213,331 ) — Loss on sale of investment in OCHL (2,790,073 ) — Total other income (expense) (8,749,918 ) 192,055 Net loss $ (15,764,719 ) $ (3,772,945 ) Net Loss per common share – basic and diluted $ (0.16 ) $ (0.04 ) Weighted average common shares – basic and diluted 99,596,206 92,082,796

Organization, Operations and 31

Organization, Operations and Basis of Presentation (Details) - USD ($)	12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015
Organization operations and basis of presentation (Textual)
Stockholders' equity (deficit)	$ (3,405,692)	$ 230,724	$ 2,403,311
Net loss	(14,249,719)	(3,746,944)
Net cash used in operating activities	$ (3,123,169)	$ (2,999,942)
Forward stock split	In September 2016, the Company's Board of Directors declared a 2-for-1 forward stock split of the Company's common stock in the form of a dividend.

Significant Accounting Polici32

Significant Accounting Policies and Practices (Details)	12 Months Ended
	Mar. 31, 2017
LiveXLive Tickets, Inc. [Member]
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]
Name of consolidated subsidiary or entity	LiveXLive Tickets, Inc.
State or other jurisdiction of incorporation or organization	Delaware
Date of incorporation or formation (date of acquisition, if applicable)	Apr. 24, 2017
Attributable interest	100.00%
LXL Studios, Inc. [Member]
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]
Name of consolidated subsidiary or entity	LXL Studios, Inc.
State or other jurisdiction of incorporation or organization	Delaware
Date of incorporation or formation (date of acquisition, if applicable)	Jul. 15, 2016
Attributable interest	100.00%
LiveXLive, Corp. [Member]
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]
Name of consolidated subsidiary or entity	LiveXLive, Corp.
State or other jurisdiction of incorporation or organization	Delaware
Date of incorporation or formation (date of acquisition, if applicable)	Feb. 24, 2015
Attributable interest	100.00%
KOKO (Camden) Holdings (US), Inc. [Member]
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]
Name of consolidated subsidiary or entity	KOKO (Camden) Holdings (US), Inc.
State or other jurisdiction of incorporation or organization	Delaware
Date of incorporation or formation (date of acquisition, if applicable)	Mar. 17, 2014
Attributable interest	100.00%
KOKO (Camden) UK Limited [Member]
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]
Name of consolidated subsidiary or entity	KOKO (Camden) UK Limited
State or other jurisdiction of incorporation or organization	England and Wales
Date of incorporation or formation (date of acquisition, if applicable)	Nov. 7, 2013
Attributable interest	100.00%

Significant Accounting Polici33

Significant Accounting Policies and Practices (Details Textual) - shares	12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Significant Accounting Policies and Practices (Textual)
Warrants outstanding	150,000	3,600,000
Anti-dilutive shares issued	3,028,325	410,260

Equity Investment in OCHL (Deta

Equity Investment in OCHL (Details) - USD ($)	8 Months Ended	12 Months Ended
	Nov. 24, 2016	Mar. 31, 2017	Mar. 31, 2016
Equity Investments in OCHL [Abstract]
Initial Investment at beggining	$ 4,889,515	$ 4,889,515	$ 4,478,962
50% share of net income for the period	132,832		410,553
Initial Investment at ending	5,022,347		4,889,515
Proceeds received	(2,182,274)
Liability extinguished	$ (50,000)
Loss recognized		$ (2,790,073)

Equity Investment in OCHL (De35

Equity Investment in OCHL (Details 1) - USD ($)	8 Months Ended	12 Months Ended
	Nov. 24, 2016	Mar. 31, 2016
Equity Investments in OCHL [Abstract]
Revenue	$ 3,921,204	$ 6,754,707
Cost of revenue	546,480	920,667
Gross profit	3,374,724	5,834,040
Operating expenses
Selling, general and administrative	2,893,306	4,613,058
Depreciation and amortization	74,828	133,106
Total operating expenses	2,968,134	4,746,164
Income from operations before other expenses	406,590	1,087,876
Other expenses
Interest	28,002	45,997
Income before provision for taxes	378,588	1,041,879
Taxes	112,924	220,773
Net income	$ 265,664	$ 821,105

Equity Investment in OCHL (De36

Equity Investment in OCHL (Details 2)	Mar. 31, 2016USD ($)
Current assets
Cash and cash equivalents	$ 386,009
Accounts receivable	24,743
Inventory	62,548
Prepaid expenses and other current assets	533,128
Total current assets	1,006,429
Other assets
Property and equipment, net of accumulated depreciation	867,975
Total assets	1,874,205
Current liabilities
Accounts payable	514,488
Taxes payable	410,504
Notes payable, current	207,978
Other accrued liabilities	460,290
Total current liabilities	1,593,210
Deferred rent - noncurrent	937,459
Total liabilities	2,530,669
Shareholders deficit	(656,464)
Total Liabilities and Shareholders' Deficit	$ 1,874,205

Equity Investment in OCHL (De37

Equity Investment in OCHL (Details Textual) - USD ($)	Apr. 28, 2014	Nov. 24, 2016	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015
Equity method investment		$ 5,022,347		$ 4,889,515	$ 4,478,962
Due to affiliate				213,331
Sale of equity investment		$ 2,182,274
Gain (Loss) on Sale of Investments			$ (2,790,073)
Impairment Of Note Receivable Related Party			$ 213,331
JJAT Corp. [Member]
Number of shares issued	58,000,000
Equity method investment	$ 4,200,000
Obar Camden Holdings Limited [Member]
Percentage of equity method ownership	50.00%
Equity method investment aggregate cost	$ 494,750

Property and Equipment (Details

Property and Equipment (Details) - USD ($)	Mar. 31, 2017	Mar. 31, 2016
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 93,382	$ 74,429
Accumulated depreciation	(35,975)	(11,860)
Fixed assets, net	57,407	62,569
Production equipment [Member]
Property, Plant and Equipment [Line Items]
Total property and equipment	51,304	51,304
Computer equipment [Member]
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 42,078	$ 23,125

Property and Equipment (Detai39

Property and Equipment (Details Textual) - USD ($)	12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Property and Equipment (Textual)
Depreciation expense	$ 24,115	$ 6,336

Notes Payable to Major Stockh40

Notes Payable to Major Stockholder (Details) - USD ($)		Mar. 31, 2017	Mar. 31, 2016
Note payable, shareholder		$ 3,603,446	$ 2,784,000
6% Unsecured Convertible Note [Member]
Note payable, shareholder	[1]	3,603,446
First Senior Note [Member]
Note payable, shareholder	[2]		1,000,000
Second Senior Note [Member]
Note payable, shareholder	[3]		$ 1,784,000
[1]	(C) 6% Unsecured Convertible Note Trinad Capital Master Fund On February 21, 2017, the Company issued a 6% unsecured convertible note payable to Trinad Capital to convert aggregate principal and interest of $3,581,077 under the First and Second Senior Notes with Trinad Capital discussed above. This convertible note is due on March 31, 2018. Before its maturity, the noteholder shall in its sole discretion have the option to convert all outstanding principal and interest into the Company's common stock at a conversion price per share based upon the Company's current valuation, as determined by the Board of Directors. If the Company raises a minimum of $5,000,000 (excluding the amount converting pursuant to the note) of aggregate gross proceeds from an equity financing in one or more closings prior to the maturity date, Trinad Capital will have the right to convert all outstanding note principal and interest into the same equity securities issued in such equity financing at 75% of the issuance price of the securities issued in such financing. In addition, Trinad Capital received 1,790,539 warrants to purchase shares of the Company's common stock at an exercise price of $0.01 per share. The warrants were exercised on February 28, 2017. The conversion of the First and Second Senior Notes into an unsecured convertible note and warrants was considered to be a debt restructuring that is accounted for as a debt extinguishment. The aggregate relative fair value of the 1,790,539 warrants issued to the noteholder was determined to be $1,624,474 using the Black-Scholes-Merton Option Pricing model with the following average assumptions: risk-free interest rate of 1.50%; dividend yield of 0%; volatility rate of 100%; and an expected life of three years (statutory term). As of February 21, 2016, the effective conversion price was $0.91, and the market price of the shares on the date of conversion was approximately $1.67 per share. As such, the Company recognized a beneficial conversion feature of $1,624,474. The relative fair value of the warrants and the note's beneficial conversion feature totaling $3,248,948 was expensed as of March 31, 2017. At March 31, 2017, the balance of the note and accrued interest were $3,581,077 and $22,369, respectively.
[2]	(A) First Senior Note Trinad Capital Master Fund On December 31, 2014, the Company entered into a senior convertible promissory note (the "First Senior Note") with Trinad Capital allowing for advances up to a maximum loan amount of $1,000,000, plus interest at the rate of 6% per annum on the unpaid principal amount of outstanding advances. At the time the First Senior Note was made, Trinad Capital advanced $700,000 to the Company and had accrued $70,151 in unpaid interest. Pursuant to the terms of the Senior Note, all outstanding unpaid principal and accrued interest was originally due and payable on June 30, 2016 or such later date as Trinad Capital may agree to in writing unless, prior to such date, the First Senior Note has been repaid in full or Trinad Capital elects to convert all or any portion of the then-outstanding loan balance into common stock of the Company in connection with the Company consummating an equity financing in excess of $5,000,000 or greater as set forth in the terms of the First Senior Note. Subsequent to the making of the First Senior Note: ? On January 27, 2015, the Company and Trinad Capital entered into an amendment to the First Senior Note, effective as of December 31, 2014, pursuant to which: (1) the term of the First Senior Note was extended to June 30, 2016 and (2) the conversion price for conversion of the unpaid balance and interest outstanding in connection with an equity financing was amended to be the price per share equal to the average price per share paid by investors in such equity financing; ? On February 5, 2015, the Company and Trinad Capital amended and restated the First Senior Note, effective as of December 31, 2014, to eliminate the convertibility feature of the note was eliminated in its entirety; and ? On April 21, 2016, the First Senior Note was further amended to extend its maturity date to June 30, 2017, or such later date as Trinad Capital may agree to in writing. For extending the due date of the First Senior Note to June 30, 2017, the Company issued to Trinad Capital warrants to purchase 1,144,986 shares of its common stock, with an exercise price of $0.005 per share and expiration date of April 21, 2020. During the fiscal year ended March 31, 2017, these warrants were fully exercised. The aggregate fair value of the 1,144,986 warrants were valued at $567,282 using the Black-Scholes-Merton Option Pricing model with the following average assumptions: risk-free interest rate of 1.30%; dividend yield of 0%; volatility rate of 100%; and an expected life of four years (statutory term). The maturity date extension was considered to be a debt restructuring that is accounted for as a debt extinguishment. Therefore, the value of the warrants was expensed as of April 21, 2016. As of March 31, 2016, $1,000,000 of principal was outstanding under the First Senior Note and accrued interest $140,555 is reflected on the consolidated balance sheet as accrued interest payable, related party as of March 31, 2016. On February 21, 2017, aggregate principal and accrued interest of $1,197,897 due under this note was exchanged into a convertible note discussed below (C).
[3]	(B) Second Senior Note Trinad Capital Master Fund On April 8, 2015, the Company entered into a second senior promissory note (the "Second Senior Note") with Trinad Capital in the amount of $195,500. The Second Senior Note bears interest at the rate of eight percent (8%) per annum and all outstanding unpaid principal and accrued interest is due and payable on June 30, 2016 or such later date as Trinad Capital may agree to in writing, unless prior to such date this note has been prepaid in full. During the year ended March 31, 2016, Trinad Capital made advances to the Company totaling $1,784,000. Subsequent to the making of the Second Senior Note: ? On July 10, 2015, the Second Senior Note was amended and restated to increase the principal amount from $195,500 to the lesser of (i) $1,000,000 (the "Maximum Advance Amount"), or (ii) the aggregate unpaid principal amount of the advances; ? On November 23, 2015, Second Senior Note was amended the Second Senior Note to increase the Maximum Advance Amount to $2,000,000; and ? On April 26, 2016, the Second Senior Note was amended to increase the Maximum Advance Amount to $3,000,000 and to extend the maturity date to June 30, 2017 or such later date as Trinad Capital may agree to in writing. For extending the due date of the Second Senior Note to June 30, 2017, the Company issued to Trinad Capital warrants to purchase 2,207,768 shares of its common stock, with an exercise price of $0.005 per share and expiration date of April 21, 2020. During the fiscal year ended March 31, 2017, these warrants were fully exercised. The aggregate fair value of the 2,207,768 warrants issued upon extension of the note were valued at $1,093,832 using the Black-Scholes-Merton Option Pricing model with the following average assumptions: risk-free interest rate of 1.30%; dividend yield of 0%; volatility rate of 100%; and an expected life of four years (statutory term). The maturity date extension was considered to be a debt restructuring that is accounted for as a debt extinguishment. Therefore, the value of the warrants was expensed as of April 21, 2016. The amount due to Trinad Capital under the Second Senior Note was $1,784,000 at March 31, 2016. During the year ended March 31, 2017, Trinad Capital made additional advances to the Company under the Second Senior Note totaling $820,100. The Company also made repayments of the Second Senior Note totaling $450,000 during year ended March 31, 2017. As of February 21, 2016, $2,154,100 of principal was outstanding under the Second Senior Note. Accrued interest of $87,048 is reflected on the balance sheet as accrued interest payable, related party as of March 31, 2016. On February 21, 2017, aggregate principal and accrued interest of $2,383,180 due under this note was exchanged into a convertible note discussed below (C).

Notes Payable to Major Stockh41

Notes Payable to Major Stockholder (Details Textual) - USD ($)

May 05, 2017

Jun. 06, 2016

Apr. 26, 2016

Apr. 21, 2016

Dec. 31, 2014

Feb. 21, 2017

Aug. 19, 2016

Apr. 30, 2016

Jan. 19, 2016

Jan. 27, 2015

Mar. 31, 2017

Mar. 31, 2016

Jun. 02, 2016

Feb. 21, 2016

Nov. 23, 2015

Jul. 10, 2015

Apr. 08, 2015

Mar. 31, 2015

Revised maturity date

Jun. 30, 2016

Principal notes payable

$ 3,603,446

$ 2,784,000

Accrued Interest

$ 34,772

$ 19,542

Exercise price (in dollars per share)

$ 1.67

$ 0.005

Amortized debt discount

$ 251,750

$ 9,817

Fair value of warrants

1,447,066

Maturity date

Dec. 31, 2015

Aggregate principal amount

$ 242,498

50,000

Beneficial conversion feature

$ 0.91

22,681

6% Unsecured Convertible Note [Member]

Terms of conversion feature

If the Company raises a minimum of $5,000,000 (excluding the amount converting pursuant to the note) in the aggregate in gross proceeds from an equity financing led by a reputable institutional investor in one or more closings prior to the maturity date, the noteholder will have the right to convert all outstanding principal and interest into the same equity securities issued in such qualified equity financing at 75% of the issuance price of the securities in such financing.

The Company issued three 8% unsecured convertible notes payable to investors (the "Lenders") for an aggregate amount of $200,000. These notes were due on January 19, 2018. Before the maturity date, the noteholder had in its sole discretion have the option to convert all outstanding principal and interest into the Company's common stock at a conversion price per share based upon the Company's current valuation, as determined by the Board of Directors. If the Company raises a minimum of $2,500,000 (excluding the amount converting pursuant to the notes) in the aggregate in gross proceeds from an equity financing led by a reputable institutional investor in one or more closings prior to the maturity date, the Lenders will have the right to convert all outstanding principal and interest into the same equity securities issued in such qualified equity financing at 75% of the issuance price of the securities in such financing.

Principal notes payable

[1]

$ 3,603,446

Exercise price (in dollars per share)

$ 0.005

Amortized debt discount

9,818

Expected life

4 years

Volatility rate

100.00%

Dividend yield

0.00%

Risk-free interest rate

1.30%

Aggregate relative fair value

$ 99,915

Aggregate principal amount

$ 200,000

$ 55,000

$ 200,000

Beneficial conversion feature

$ 136,936

Conversion price (in dollars per share)

$ 1

Warrant [Member]

Exercise price (in dollars per share)

$ 0.01

Beneficial conversion feature

45,362

Warrant [Member] | 6% Unsecured Convertible Note [Member]

Number of shares issued

205,920

200,000

Exercise price (in dollars per share)

$ 0.005

$ 0.01

$ 0.005

Expected life

3 years

Volatility rate

100.00%

Dividend yield

0.00%

Risk-free interest rate

1.20%

Aggregate relative fair value

$ 341,864

$ 341,864

Subsequent Event [Member]

Number of shares issued

2,000,000

Trinad Capital [Member] | 6% Unsecured Convertible Note [Member]

Principal notes payable

3,581,077

Accrued Interest

22,369

Exercise price (in dollars per share)

$ 0.01

Maturity date

Mar. 31, 2018

Remaining management service payable

$ 1,624,474

Volatility rate

100.00%

Dividend yield

0.00%

Risk-free interest rate

1.50%

Aggregate relative fair value

$ 1,790,539

3,248,948

Conversion price (in dollars per share)

$ 0.91

Warrants to purchase shares of common stock

$ 1,790,539

Description of debt

If the Company raises a minimum of $5,000,000 (excluding the amount converting pursuant to the note) of aggregate gross proceeds from an equity financing in one or more closings prior to the maturity date, Trinad Capital will have the right to convert all outstanding note principal and interest into the same equity securities issued in such equity financing at 75% of the issuance price of the securities issued in such financing.

Trinad Capital [Member] | Warrant [Member]

Accrued Interest

$ 140,555

Number of shares issued

3,352,754

Exercise price (in dollars per share)

$ 0.005

Principal notes payable

1,000,000

Aggregate principal amount

700,000

First Senior Note [Member]

Principal notes payable

[2]

1,000,000

First Senior Note [Member] | As Restated [Member] | 6% Unsecured Convertible Note [Member]

Principal notes payable

$ 825,000

First Senior Note [Member] | Trinad Capital [Member]

Revised maturity date

Jun. 30, 2017

Principal notes payable

1,000,000

Accrued Interest

70,151

$ 0

140,555

Exercise price (in dollars per share)

$ 0.01

Aggregate principal amount

$ 1,000,000

$ 1,197,897

Interest rate of per annum

6.00%

First Senior Note [Member] | Trinad Capital [Member] | 6% Unsecured Convertible Note [Member]

Aggregate principal amount

$ 3,581,077

Interest rate of per annum

6.00%

First Senior Note [Member] | Trinad Capital [Member] | Warrant [Member]

Number of shares issued

1,144,986

Exercise price (in dollars per share)

$ 0.005

Expiration date

Apr. 21, 2020

Expected life

4 years

Warrants issued

1,144,986

Volatility rate

100.00%

Dividend yield

0.00%

Risk-free interest rate

1.30%

Aggregate relative fair value

$ 567,282

First Senior Note [Member] | Trinad Management Llc [Member]

Converted value in excess of principal

$ 1,000,000

$ 5,000,000

Terms of conversion feature

The conversion price for conversion of the unpaid balance and interest outstanding in connection with an equity financing was amended to be the price per share equal to the average price per share paid by investors in such equity financing.

Maturity date

Jun. 30, 2016

First Senior Note [Member] | Trinad Management Llc [Member] | Warrant [Member]

Number of shares issued

1,144,986

Exercise price (in dollars per share)

$ 0.005

Expected life

4 years

Warrants issued

1,144,986

Volatility rate

100.00%

Dividend yield

0.00%

Risk-free interest rate

1.30%

Aggregate relative fair value

$ 567,282

Second Senior Note [Member]

Principal notes payable

[3]

$ 1,784,000

Second Senior Note [Member] | As Restated [Member] | 6% Unsecured Convertible Note [Member]

Principal notes payable

Second Senior Note [Member] | Trinad Capital [Member]

Maturity date

Jun. 30, 2016

Revised maturity date

Jun. 30, 2017

Principal notes payable

$ 1,784,000

$ 2,154,100

Accrued Interest

87,048

Exercise price (in dollars per share)

$ 0.01

Principal notes payable

1,784,000

Aggregate principal amount

$ 3,000,000

$ 2,383,180

$ 1,784,000

$ 2,000,000

$ 1,000,000

$ 195,500

Interest rate of per annum

8.00%

Second Senior Note [Member] | Trinad Capital [Member] | 6% Unsecured Convertible Note [Member]

Aggregate principal amount

$ 3,581,077

Interest rate of per annum

6.00%

Second Senior Note [Member] | Trinad Capital [Member] | Warrant [Member]

Revised maturity date

Jun. 30, 2017

Number of shares issued

2,207,768

Exercise price (in dollars per share)

$ 0.005

Expiration date

Apr. 21, 2020

Expected life

4 years

Warrants issued

2,207,768

Fair value of warrants

$ 1,093,832

Repayment of notes payable

$ 450,000

Maturity date

Jun. 30, 2017

Volatility rate

100.00%

Dividend yield

0.00%

Risk-free interest rate

1.30%

Aggregate principal amount

$ 3,000,000

$ 820,100

Second Senior Note [Member] | Trinad Capital [Member] | As Restated [Member]

Aggregate principal amount

$ 195,500

[1]

(C) 6% Unsecured Convertible Note Trinad Capital Master Fund On February 21, 2017, the Company issued a 6% unsecured convertible note payable to Trinad Capital to convert aggregate principal and interest of $3,581,077 under the First and Second Senior Notes with Trinad Capital discussed above. This convertible note is due on March 31, 2018. Before its maturity, the noteholder shall in its sole discretion have the option to convert all outstanding principal and interest into the Company's common stock at a conversion price per share based upon the Company's current valuation, as determined by the Board of Directors. If the Company raises a minimum of $5,000,000 (excluding the amount converting pursuant to the note) of aggregate gross proceeds from an equity financing in one or more closings prior to the maturity date, Trinad Capital will have the right to convert all outstanding note principal and interest into the same equity securities issued in such equity financing at 75% of the issuance price of the securities issued in such financing. In addition, Trinad Capital received 1,790,539 warrants to purchase shares of the Company's common stock at an exercise price of $0.01 per share. The warrants were exercised on February 28, 2017. The conversion of the First and Second Senior Notes into an unsecured convertible note and warrants was considered to be a debt restructuring that is accounted for as a debt extinguishment. The aggregate relative fair value of the 1,790,539 warrants issued to the noteholder was determined to be $1,624,474 using the Black-Scholes-Merton Option Pricing model with the following average assumptions: risk-free interest rate of 1.50%; dividend yield of 0%; volatility rate of 100%; and an expected life of three years (statutory term). As of February 21, 2016, the effective conversion price was $0.91, and the market price of the shares on the date of conversion was approximately $1.67 per share. As such, the Company recognized a beneficial conversion feature of $1,624,474. The relative fair value of the warrants and the note's beneficial conversion feature totaling $3,248,948 was expensed as of March 31, 2017. At March 31, 2017, the balance of the note and accrued interest were $3,581,077 and $22,369, respectively.

[2]

(A) First Senior Note Trinad Capital Master Fund On December 31, 2014, the Company entered into a senior convertible promissory note (the "First Senior Note") with Trinad Capital allowing for advances up to a maximum loan amount of $1,000,000, plus interest at the rate of 6% per annum on the unpaid principal amount of outstanding advances. At the time the First Senior Note was made, Trinad Capital advanced $700,000 to the Company and had accrued $70,151 in unpaid interest. Pursuant to the terms of the Senior Note, all outstanding unpaid principal and accrued interest was originally due and payable on June 30, 2016 or such later date as Trinad Capital may agree to in writing unless, prior to such date, the First Senior Note has been repaid in full or Trinad Capital elects to convert all or any portion of the then-outstanding loan balance into common stock of the Company in connection with the Company consummating an equity financing in excess of $5,000,000 or greater as set forth in the terms of the First Senior Note. Subsequent to the making of the First Senior Note: ? On January 27, 2015, the Company and Trinad Capital entered into an amendment to the First Senior Note, effective as of December 31, 2014, pursuant to which: (1) the term of the First Senior Note was extended to June 30, 2016 and (2) the conversion price for conversion of the unpaid balance and interest outstanding in connection with an equity financing was amended to be the price per share equal to the average price per share paid by investors in such equity financing; ? On February 5, 2015, the Company and Trinad Capital amended and restated the First Senior Note, effective as of December 31, 2014, to eliminate the convertibility feature of the note was eliminated in its entirety; and ? On April 21, 2016, the First Senior Note was further amended to extend its maturity date to June 30, 2017, or such later date as Trinad Capital may agree to in writing. For extending the due date of the First Senior Note to June 30, 2017, the Company issued to Trinad Capital warrants to purchase 1,144,986 shares of its common stock, with an exercise price of $0.005 per share and expiration date of April 21, 2020. During the fiscal year ended March 31, 2017, these warrants were fully exercised. The aggregate fair value of the 1,144,986 warrants were valued at $567,282 using the Black-Scholes-Merton Option Pricing model with the following average assumptions: risk-free interest rate of 1.30%; dividend yield of 0%; volatility rate of 100%; and an expected life of four years (statutory term). The maturity date extension was considered to be a debt restructuring that is accounted for as a debt extinguishment. Therefore, the value of the warrants was expensed as of April 21, 2016. As of March 31, 2016, $1,000,000 of principal was outstanding under the First Senior Note and accrued interest $140,555 is reflected on the consolidated balance sheet as accrued interest payable, related party as of March 31, 2016. On February 21, 2017, aggregate principal and accrued interest of $1,197,897 due under this note was exchanged into a convertible note discussed below (C).

[3]

(B) Second Senior Note Trinad Capital Master Fund On April 8, 2015, the Company entered into a second senior promissory note (the "Second Senior Note") with Trinad Capital in the amount of $195,500. The Second Senior Note bears interest at the rate of eight percent (8%) per annum and all outstanding unpaid principal and accrued interest is due and payable on June 30, 2016 or such later date as Trinad Capital may agree to in writing, unless prior to such date this note has been prepaid in full. During the year ended March 31, 2016, Trinad Capital made advances to the Company totaling $1,784,000. Subsequent to the making of the Second Senior Note: ? On July 10, 2015, the Second Senior Note was amended and restated to increase the principal amount from $195,500 to the lesser of (i) $1,000,000 (the "Maximum Advance Amount"), or (ii) the aggregate unpaid principal amount of the advances; ? On November 23, 2015, Second Senior Note was amended the Second Senior Note to increase the Maximum Advance Amount to $2,000,000; and ? On April 26, 2016, the Second Senior Note was amended to increase the Maximum Advance Amount to $3,000,000 and to extend the maturity date to June 30, 2017 or such later date as Trinad Capital may agree to in writing. For extending the due date of the Second Senior Note to June 30, 2017, the Company issued to Trinad Capital warrants to purchase 2,207,768 shares of its common stock, with an exercise price of $0.005 per share and expiration date of April 21, 2020. During the fiscal year ended March 31, 2017, these warrants were fully exercised. The aggregate fair value of the 2,207,768 warrants issued upon extension of the note were valued at $1,093,832 using the Black-Scholes-Merton Option Pricing model with the following average assumptions: risk-free interest rate of 1.30%; dividend yield of 0%; volatility rate of 100%; and an expected life of four years (statutory term). The maturity date extension was considered to be a debt restructuring that is accounted for as a debt extinguishment. Therefore, the value of the warrants was expensed as of April 21, 2016. The amount due to Trinad Capital under the Second Senior Note was $1,784,000 at March 31, 2016. During the year ended March 31, 2017, Trinad Capital made additional advances to the Company under the Second Senior Note totaling $820,100. The Company also made repayments of the Second Senior Note totaling $450,000 during year ended March 31, 2017. As of February 21, 2016, $2,154,100 of principal was outstanding under the Second Senior Note. Accrued interest of $87,048 is reflected on the balance sheet as accrued interest payable, related party as of March 31, 2016. On February 21, 2017, aggregate principal and accrued interest of $2,383,180 due under this note was exchanged into a convertible note discussed below (C).

Related Party Unsecured Conve42

Related Party Unsecured Convertible Notes Payable (Details) - USD ($)		Mar. 31, 2017	Mar. 31, 2016
Debt Instrument [Line Items]
Principal notes payable		$ 1,403,149	$ 200,000
Less accumulated amortization of Valuation Discount		(1,114,751)	(89,727)
Net		11,668
6% Unsecured Convertible Note - due September 13, 2018
Debt Instrument [Line Items]
Principal notes payable	[1]
6% Unsecured Convertible Note - due on March 31, 2018
Debt Instrument [Line Items]
Principal notes payable	[2]	$ 50,707
[1]	(A) Convertible Note JJAT On August 19, 2016, the Company issued a 6% unsecured convertible note payable to a related party for total principal amount of $55,000. This note was due on September 30, 2018. Before its maturity, the noteholder had in its sole discretion have the option to convert all outstanding principal and interest into the Company's common stock at a conversion price per share based upon the Company's current valuation, as determined by the Board of Directors. If the Company raises a minimum of $5,000,000 (excluding the amount converting pursuant to the note) in the aggregate in gross proceeds from an equity financing led by a reputable institutional investor in one or more closings prior to the maturity date, the noteholder will have the right to convert all outstanding principal and interest into the same equity securities issued in such qualified equity financing at 75% of the issuance price of the securities in such financing. On December 21, 2016, this note was repaid.
[2]	(B) Convertible Note Marvin Ellin On January 4, 2017, the Company issued a 6% unsecured convertible note payable to a certain investor for total principal amount of $50,000. This note will be due on September 13, 2018. Before its maturity, the noteholder shall in its sole discretion have the option to convert all outstanding principal and interest into the Company's common stock at a conversion price per share based upon the Company's current valuation, as determined by the Board of Directors. If the Company raises a minimum of $5,000,000 (excluding the amount converting pursuant to the note) of aggregate gross proceeds from an equity financing in one or more closings prior to the maturity date, the noteholder will have the right to convert all outstanding note principal and interest into the same equity securities issued in such equity financing at 75% of the issuance price of the securities issued in such financing. In addition, the noteholder received 25,000 warrants to purchase shares of the Company's common stock at an exercise price of $0.01 per share. The aggregate relative fair value of the 25,000 warrants issued to the investor was determined to be $22,681 using the Black-Scholes-Merton Option Pricing model with the following average assumptions: risk-free interest rate of 1.50%; dividend yield of 0%; volatility rate of 100%; and an expected life of three years (statutory term). As of February 21, 2017, the effective conversion price was $0.91, and the market price of the shares on the date of conversion was approximately $1.67 per share. As such, the Company recognized a beneficial conversion feature of $22,681. The aggregate value of the warrants and beneficial conversion feature of $45,362 was considered as debt discount upon issuance and will be amortized as interest over the term of the note or in full upon the conversion of the note. During year ended March 31, 2017, the Company amortized $6,323 of such discount to interest expense, and the unamortized discount as of March 31, 2017 was $39,039. As of March 31, 2017, $50,000 of principal and $707 of accrued interest was due under the note.

Related Party Unsecured Conve43

Related Party Unsecured Convertible Notes Payable (Details Textual) - USD ($)	Jan. 04, 2017	Aug. 19, 2016	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2014
Related Party Unsecured Convertible Notes Payable [Textual]
Principal amount			$ 50,000		$ 242,498
Exercise price (in dollars per share)			$ 1.67	$ 0.005
Unamortized debt discount			$ (1,114,751)	$ (89,727)
6% Unsecured Convertible Note due September 13, 2018 [Member]
Related Party Unsecured Convertible Notes Payable [Textual]
Principal amount		$ 55,000
Unsecured convertible note payable		6.00%
Unsecured convertible note payable due			Sep. 30, 2018
Aggregate in gross proceeds			$ 5,000,000
Financing issuance price			75.00%
6% Unsecured Convertible Note due on March 31, 2018 [Member]
Related Party Unsecured Convertible Notes Payable [Textual]
Principal amount	$ 50,000
Unsecured convertible note payable	6.00%
Unsecured convertible note payable due			Sep. 13, 2018
Aggregate in gross proceeds			$ 5,000,000
Financing issuance price			75.00%
Exercise price (in dollars per share)			$ 0.01
Shares issued during the period			25,000
Number of shares of aggregate relative fair value			25,000
Aggregate relative fair value			$ 22,681
Risk-free interest rate			1.50%
Dividend yield			0.00%
Volatility rate			100.00%
Expected life			3 years
Terms of conversion feature			The effective conversion price was $0.91, and the market price of the shares on the date of conversion was approximately $1.67 per share. As such, the Company recognized a beneficial conversion feature of $22,681. The aggregate value of the warrants and beneficial conversion feature of $45,362 was considered as debt discount upon issuance and will be amortized as interest over the term of the note or in full upon the conversion of the note.
Conversion of amortized to interest expense			$ 6,323
Unamortized debt discount			39,039
Accrued interest			$ 707

Unsecured Convertible Notes P44

Unsecured Convertible Notes Payable (Details) - USD ($)		Mar. 31, 2017	Mar. 31, 2016
Debt Instrument [Line Items]
Principal notes payable		$ 1,403,149	$ 200,000
Less accumulated amortization of Valuation Discount		(1,114,751)	(89,727)
Net		288,398	110,273
Convertible Notes Payable, Current		67,858
Notes payable, long-term		220,540	110,273
8% Unsecured Convertible Notes - Due on January 19, 2018 [Member]
Debt Instrument [Line Items]
Principal notes payable	[1]		200,000
6% Unsecured Convertible Notes - Due on September 13, 2018 [Member]
Debt Instrument [Line Items]
Principal notes payable	[2]	154,882
Less accumulated amortization of Valuation Discount		109,259
6% Unsecured Convertible Notes - Due between January 31, 2018 and September 30, 2018 [Member]
Debt Instrument [Line Items]
Principal notes payable	[3]	1,248,267
Less accumulated amortization of Valuation Discount		$ 1,004,590
[1]	On January 19, 2016, the Company issued three 8% unsecured convertible notes payable to investors (the "Lenders") for an aggregate amount of $200,000. These notes were due on January 19, 2018. Before the maturity date, the noteholder had in its sole discretion have the option to convert all outstanding principal and interest into the Company's common stock at a conversion price per share based upon the Company's current valuation, as determined by the Board of Directors. If the Company raises a minimum of $2,500,000 (excluding the amount converting pursuant to the notes) in the aggregate in gross proceeds from an equity financing led by a reputable institutional investor in one or more closings prior to the maturity date, the Lenders will have the right to convert all outstanding principal and interest into the same equity securities issued in such qualified equity financing at 75% of the issuance price of the securities in such financing. In addition, the Lenders received 400,000 warrants to purchase shares of the Company's common stock at an exercise price of $0.005 per share. The warrants were exercised during the year ended March 31, 2017. The aggregate relative fair value of the 400,000 warrants issued to the Lender was determined to be $99,915 using the Black-Scholes-Merton Option Pricing model with the following average assumptions: risk-free interest rate of 1.30%; dividend yield of 0%; volatility rate of 100%; and an expected life of four years (statutory term). The value of the warrants of $99,915 was considered as debt discount upon issuance and was being amortized as interest over the term of the notes or in full upon the conversion of the corresponding notes. During the year ended March 31, 2016, the Company amortized $9,818 of such discount to interest expense, and the unamortized discount as of March 31, 2016 was $89,727. On June 6, 2016, the Lenders converted $200,000 of principal and $5,918 of interest into 205,918 shares of the Company's common stock at a conversion price of $1 per share. As the market price of the shares on the date of conversion was approximately $1.67 per share, the Company recognized a beneficial conversion cost of $136,936. As a result of the conversion, the remaining debt discount of $89,727 was fully amortized to interest expense as of the date of conversion. As an inducement for the conversion, the Lenders were issued 205,920 warrants to purchase shares of the Company's common stock at an exercise price of $0.005 per share. The aggregate fair value of the 205,920 warrants issued to the Lenders was $341,864 using the Black-Scholes-Merton Option Pricing model with the following average assumptions: risk-free interest rate of 1.20%; dividend yield of 0%; volatility rate of 100%; and an expected life of three years (statutory term). The value of the warrants of $341,864 was considered as additional interest expense upon their issuance. The warrants were exercised immediately into 205,920 shares of the Company's common stock with net proceeds of $1,030 to the Company.
[2]	On September 14, 2016, the Company issued a 6% unsecured convertible note payable to a certain investor for total principal amount of $150,000. This note will be due on September 13, 2018. Before the maturity date, the noteholder shall in its sole discretion have the option to convert all outstanding principal and interest into the Company's common stock at a conversion price per share based upon the Company's current valuation, as determined by the Board of Directors. If the Company raises a minimum of $5,000,000 (excluding the amount converting pursuant to the note) of aggregate gross proceeds from an equity financing in one or more closings prior to the maturity date, the noteholder will have the right to convert all outstanding note principal and interest into the same equity securities issued in such equity financing at 75% of the issuance price of the securities issued in such financing. In addition, the noteholder received 150,000 warrants to purchase shares of the Company's common stock at an exercise price of $0.005 per share. The aggregate relative fair value of the 150,000 warrants issued to the noteholder was determined to be $93,612 using the Black-Scholes-Merton Option Pricing model with the following average assumptions: risk-free interest rate of 0.90%; dividend yield of 0%; volatility rate of 100%; and an expected life of three years (statutory term). As of September 14, 2016, the effective conversion price was $0.63, and the market price of the shares on the date of conversion was approximately $1.67 per share. As such, the Company recognized a beneficial conversion feature of $56,388. As a result, the Company recorded a note discount of $150,000 to account for the relative fair value of the warrants and the notes' beneficial conversion feature which will be amortized as interest over the term of the note. During year ended March 31, 2017, the Company amortized $40,741 of such discount to interest expense, and the unamortized discount as of March 31, 2017 was $109,259. As of March 31, 2017, $4,882 accrued interest was added to principal balance.
[3]	Between November 22, 2016 and March 27, 2017, the Company issued seven 6% unsecured convertible notes payable to certain investors for aggregate total principal of $1,235,000. The notes are due on various dates through September 30, 2018. Before the maturity date, the noteholders shall in their sole discretion have the option to convert all outstanding principal and interest into the Company's common stock at a conversion price per share based upon the Company's current valuation, as determined by the Board of Directors. If the Company raises a minimum of $5,000,000 (excluding the amount converting pursuant to the note) of aggregate gross proceeds from an equity financing in one or more closings prior to the maturity date, the noteholders will have the right to convert all outstanding note principal and interest into the same equity securities issued in such equity financing at 75% of the issuance price of the securities issued in such financing. In addition, the noteholders received an aggregate of 617,500 warrants to purchase shares of the Company's common stock at an exercise price of $0.01 per share. The aggregate relative fair value of the 617,500 warrants issued to the noteholders was determined to be $560,226 using the Black-Scholes-Merton Option Pricing model with the following average assumptions: risk-free interest rate of 1.35-1.53%; dividend yield of 0%; volatility rate of 100%; and an expected life of three years (statutory term). At the issuance of these notes, the effective conversion price was $0.91 and the market price of the shares on the date of conversion was approximately $1.67 per share, the Company recognized aggregate beneficial conversion features of $560,226. As a result, the Company recorded a note discount of $1,120,450 to account for the relative fair values of the warrants and the notes' beneficial conversion features which will be amortized as interest over the terms of the notes or in full upon conversion of the notes. During year ended March 31, 2017, the Company amortized $114,961 of such discount to interest expense, and the unamortized discount as of March 31, 2017 was $1,004,590.

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)

Apr. 26, 2016

Apr. 21, 2016

Dec. 31, 2014

Sep. 23, 2011

Aug. 25, 2016

Apr. 30, 2016

Jan. 27, 2015

Mar. 31, 2017

Mar. 31, 2016

Feb. 21, 2017

Nov. 23, 2015

Jul. 10, 2015

Apr. 08, 2015

Related Party Transactions (Textual)

Exercise price (in dollars per share)

$ 1.67

$ 0.005

Due to related parties

$ 117,124

Aggregate principal amount

$ 242,498

50,000

Warrant [Member]

Related Party Transactions (Textual)

Exercise price (in dollars per share)

$ 0.01

Trinad Management LLC [Member] | First Senior Note [Member]

Related Party Transactions (Textual)

Converted value in excess of principal

1,000,000

$ 5,000,000

Trinad Management LLC [Member] | Warrant [Member] | First Senior Note [Member]

Related Party Transactions (Textual)

Number of shares issued

1,144,986

Exercise price (in dollars per share)

$ 0.005

Mr. Robert Ellin [Member]

Related Party Transactions (Textual)

Due to related parties

0

$ 117,124

Trinad Capital [Member] | First Senior Note [Member]

Related Party Transactions (Textual)

Exercise price (in dollars per share)

$ 0.01

Aggregate principal amount

1,000,000

$ 1,197,897

Trinad Capital [Member] | Second Senior Note [Member]

Related Party Transactions (Textual)

Exercise price (in dollars per share)

$ 0.01

Principal notes payable

1,784,000

Aggregate principal amount

$ 3,000,000

1,784,000

$ 2,383,180

$ 2,000,000

$ 1,000,000

$ 195,500

Trinad Capital [Member] | Second Senior Note [Member] | As Restated [Member]

Related Party Transactions (Textual)

Aggregate principal amount

$ 195,500

Trinad Capital [Member] | Warrant [Member]

Related Party Transactions (Textual)

Number of shares issued

3,352,754

Exercise price (in dollars per share)

$ 0.005

Principal notes payable

1,000,000

Aggregate principal amount

$ 700,000

Trinad Capital [Member] | Warrant [Member] | First Senior Note [Member]

Related Party Transactions (Textual)

Number of shares issued

1,144,986

Exercise price (in dollars per share)

$ 0.005

Trinad Capital [Member] | Warrant [Member] | Second Senior Note [Member]

Related Party Transactions (Textual)

Number of shares issued

2,207,768

Exercise price (in dollars per share)

$ 0.005

Repayment of notes payable

450,000

Aggregate principal amount

$ 3,000,000

820,100

Management Services Agreement [Member] | Trinad Management LLC [Member]

Related Party Transactions (Textual)

Management service fee

$ 2,080,000

360,000

360,000

Management service payable

90,000

30,000

Due to related parties

$ 1,000,000

239,080

$ 1,000,000

Agreement term

3 years

Repayment of notes payable

$ 750,000

Management Services Agreement [Member] | Trinad Management LLC [Member] | Warrant [Member]

Related Party Transactions (Textual)

Number of shares issued

2,148,648

Exercise price (in dollars per share)

$ 0.075

Expiration period

10 years

Amortized period

3 years

Management Services Agreement [Member] | Trinad Management LLC [Member] | Warrant 1 [Member]

Related Party Transactions (Textual)

Number of shares issued

2,250,000

Exercise price (in dollars per share)

$ 0.075

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)	May 05, 2017	Sep. 22, 2016	May 20, 2016	Apr. 28, 2014	Nov. 24, 2016	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2014
Name of plaintiff			Mr. Oliver Bengough
Name of defendant			OCHL, OCL, KOKO UK and Mr. Ellin (collectively, the "Respondents").
Domicile of litigation			High Court of Justice, Chancery Division (the “Court”)
Description of allegations			In the Petition, Mr. Bengough claimed, among other things, certain breaches of duty by Mr. Ellin in connection with the corporate operations of the Respondents, as well as a "deterioration" of the relationship between the parties. OCHL was formed by OCL's stockholders for the sole purpose of acquiring all of the registered and contributed capital of OCL, is a 50%-owned subsidiary of the Company and is the former parent of OCL.
Aggregate principal amount						$ 50,000		$ 242,498
Payment of acquisition of promotional rights						$ 350,000
Jjat Corp [Member]
Number of shares issued				58,000,000
BTG Financial Consulting LLP [Member]
Description Of Agreement Terms					The parties and that its analysis yielded that the value of the ordinary shares of OCHL is $4,455,833 (£3,612,057), therefore entitling the Company to $2,182,274 (£1,769,029) (or 50% of the value) minus $45,643 (£37,000) (as agreed to by the parties).
Litigation Case [Member]
Name of plaintiff			Mr. Oliver Bengough
Name of defendant			OCHL, OCL, KOKO UK and Mr. Ellin (collectively, the "Respondents").
Domicile of litigation			High Court of Justice, Chancery Division (the "Court")
Description of allegations			In the Petition, Mr. Bengough claimed, among other things, certain breaches of duty by Mr. Ellin in connection with the corporate operations of the Respondents, as well as a "deterioration" of the relationship between the parties. OCHL was formed by OCL's stockholders for the sole purpose of acquiring all of the registered and contributed capital of OCL, is a 50%-owned subsidiary of the Company and is the former parent of OCL.
Subsequent Event [Member]
Number of shares issued	2,000,000
Common stock [Member]
Number of shares issued							150,000
Settlement Agreement [Member] | Messrs Ellin And Bengough [Member] | Deferred Ordinary Shares [Member] | KOKO (Camden) UK Limited [Member]
Number Of Shares Sold		2,750
Settlement Agreement [Member] | Messrs Ellin And Bengough [Member] | Common stock [Member] | KOKO (Camden) UK Limited [Member]
Number Of Shares Sold		48,878
Settlement Agreement [Member] | Escrow Agent [Member] | Litigation Case [Member] | BTG Financial Consulting LLP [Member]
Description of valuation report					The parties and that its analysis yielded that the value of the ordinary shares of OCHL is £3,612,057, therefore entitling us to £1,769,029 (or 50% of the value) minus £37,000 (the "Final Sale Price").

Equity Incentive Plan (Details)

Equity Incentive Plan (Details)	Aug. 29, 2016shares
2016 Equity Incentive Plan (the "2016 Plan") [Member] | Board of Directors [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock for issuance	22,800,000

Stockholders' Equity (Deficit48

Stockholders' Equity (Deficit) (Details) - Warrant [Member] - $ / shares	12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Number of Warrants
Balance outstanding, begining	3,600,000	3,600,000
Granted	6,416,712	1,162,500
Exercised	(9,866,712)	(1,162,500)
Forfeited/expired
Balance outstanding, ending	150,000	3,600,000
Exercisable, ending	150,000	1,800,000
Weighted Average Exercise Price
Granted	$ 0.007	$ 0.005
Exercised	0.022	0.005
Forfeited/expired
Exercisable, ending	$ 0.010	$ 0.1
Weighted Average Remaining Contractual Term
Balance outstanding, Begining	2 years 11 months 26 days	4 years 1 month 27 days
Granted	2 years 10 months 28 days	2 years 2 months 16 days
Exercised	3 years 1 month 24 days	4 years 2 months 27 days
Forfeited/expired	0 years	0 years
Balance outstanding, ending	2 years 11 months 26 days	4 years 1 month 27 days
Exercisable, ending	2 years 11 months 26 days

Stockholders' Equity (Deficit49

Stockholders' Equity (Deficit) (Details Textual) - USD ($)		Nov. 22, 2016	Sep. 14, 2016	Jun. 06, 2016	Apr. 28, 2014	Apr. 30, 2016	Mar. 31, 2017	Mar. 31, 2016	Feb. 21, 2017	Nov. 24, 2016	Jun. 02, 2016	Feb. 21, 2016	Mar. 31, 2015	Dec. 31, 2014
Equity method investments								$ 4,889,515		$ 5,022,347			$ 4,478,962
Number of shares issued, value								$ 5,813
Exercise price (in dollars per share)							$ 1.67	$ 0.005
Number of shares issued upon services,value								$ 856,500
Number of warrants exercised								1,162,500
Convertible notes payable							$ 1,403,149	$ 200,000
Proceeds from warrant exercise							$ 48,123
Common stock, authorized							500,000,000	500,000,000
Preferred stock, authorized							1,000,000	1,000,000
Preferred stock, par value (in dollars per share)							$ 0.001	$ 0.001
8% Unsecured Convertible Notes Payable [Member]
Share price (in dollars per share)				$ 1.67
Exercise price (in dollars per share)							$ 0.005
Convertible notes payable	[1]							$ 200,000
Aggregate relative fair value							$ 99,915
Jjat Corp [Member]
Number of shares issued					58,000,000
Equity method investments					$ 4,200,000
Accredited Investors [Member]
Number of shares issued							947,500
Number of shares issued, value							$ 9,475
Exercise price (in dollars per share)							$ 0.01
Accredited Investors [Member] | Securities Purchase Agreements [Member]
Number of units issued							550,000	762,500
Number of units issued,value							$ 1,375,000	$ 612,500
Share price (in dollars per unit)							$ 2.50	$ 2					$ 1
Accredited Investors [Member] | Securities Purchase Agreements [Member] | Maximum [Member]
Share price (in dollars per share)								0.005
Accredited Investors [Member] | Securities Purchase Agreements [Member] | Minimum [Member]
Share price (in dollars per share)								$ 0.01
Trinad Capital [Member] | 8% Unsecured Convertible Notes Payable [Member]
Exercise price (in dollars per share)												$ 0.01
Aggregate relative fair value							$ 3,248,948		$ 1,790,539
Warrant [Member]
Number of shares issued, value								$ 5,813
Exercise price (in dollars per share)								$ 0.01
Number of warrants exercised								581,250					2,950,000
Warrant [Member] | Convertible Debt [Member]
Number of shares issued			150,000				2,583,038
Share price (in dollars per share)			$ 0.005				$ 0.01
Number of shares issued, value			$ 93,612				$ 676,518
Number of warrants exercised							966,536
Convertible notes payable							$ 48,123
Number of cashless warrants exercised							2,250,000
Warrant [Member] | Convertible Debt One [Member]
Number of shares issued		250,000
Share price (in dollars per share)		$ 0.005
Number of shares issued, value		$ 226,811
Warrant [Member] | 8% Unsecured Convertible Notes Payable [Member]
Number of shares issued				205,920				200,000
Exercise price (in dollars per share)				$ 0.005				$ 0.01			$ 0.005
Number of warrants exercised											205,920
Convertible notes payable											$ 400,000
Proceeds from warrant exercise				$ 1,030
Aggregate relative fair value				$ 341,864							$ 341,864
Warrant [Member] | Securities Purchase Agreements [Member]
Number of shares issued							275,000
Warrant [Member] | Eight Accredited Investors [Member]
Share price (in dollars per share)														$ 1
Exercise price (in dollars per share)														$ 0.01
Warrant [Member] | Accredited Investors [Member] | Securities Purchase Agreements [Member]
Number of shares in each unit							1	1
Exercise price (in dollars per share)								$ 0.005					$ 0.01
Expiration period							3 years	4 years
Warrant [Member] | Accredited Investors [Member] | Securities Purchase Agreements [Member] | Maximum [Member]
Exercise price (in dollars per share)							$ 0.005
Warrant [Member] | Accredited Investors [Member] | Securities Purchase Agreements [Member] | Minimum [Member]
Exercise price (in dollars per share)							$ 0.01
Warrant [Member] | Trinad Capital [Member]
Number of shares issued						3,352,754
Share price (in dollars per share)						$ 0.005
Number of shares issued, value						$ 1,661,114
Exercise price (in dollars per share)						$ 0.005
Proceeds from warrant exercise						$ 16,764
Common Stock [Member]
Number of shares issued								150,000
Share price (in dollars per share)								$ 1
Number of shares issued, value								$ 150,000
Number of shares issued upon services								1,802,000
Number of shares issued upon services,value								$ 1,802
Common Stock [Member] | Subscription Agreement (Legal advisors) [Member]
Share price (in dollars per share)													0.50
Common Stock [Member] | Accredited Investors [Member] | Securities Purchase Agreements [Member]
Number of shares in each unit							1	1
Common Stock [Member] | Various Consultants & Advisory Board Members [Member]
Number of shares issued upon services								901,000
Number of shares issued upon services,value								$ 856,500
Common Stock [Member] | Various Consultants & Advisory Board Members [Member] | Maximum [Member]
Share price (in dollars per share)								$ 1					1
Common Stock [Member] | Various Consultants & Advisory Board Members [Member] | Minimum [Member]
Share price (in dollars per share)								$ 0.50					$ 0.50
Common Stock [Member] | Consultants [Member]
Number of shares issued upon services							1,578,720	1,802,000
Number of shares issued upon services,value							$ 2,279,589	$ 856,500
Number of shares issued upon services to related party							100,000
Number of shares issued upon services to related party, value							$ 167,000
Common Stock [Member] | Consultants [Member] | Maximum [Member]
Share price (in dollars per unit)								$ 0.25
Number of shares in each unit							0.50
Common Stock [Member] | Consultants [Member] | Minimum [Member]
Share price (in dollars per unit)								$ 0.50
Number of shares in each unit							1.67
[1]	On January 19, 2016, the Company issued three 8% unsecured convertible notes payable to investors (the "Lenders") for an aggregate amount of $200,000. These notes were due on January 19, 2018. Before the maturity date, the noteholder had in its sole discretion have the option to convert all outstanding principal and interest into the Company's common stock at a conversion price per share based upon the Company's current valuation, as determined by the Board of Directors. If the Company raises a minimum of $2,500,000 (excluding the amount converting pursuant to the notes) in the aggregate in gross proceeds from an equity financing led by a reputable institutional investor in one or more closings prior to the maturity date, the Lenders will have the right to convert all outstanding principal and interest into the same equity securities issued in such qualified equity financing at 75% of the issuance price of the securities in such financing. In addition, the Lenders received 400,000 warrants to purchase shares of the Company's common stock at an exercise price of $0.005 per share. The warrants were exercised during the year ended March 31, 2017. The aggregate relative fair value of the 400,000 warrants issued to the Lender was determined to be $99,915 using the Black-Scholes-Merton Option Pricing model with the following average assumptions: risk-free interest rate of 1.30%; dividend yield of 0%; volatility rate of 100%; and an expected life of four years (statutory term). The value of the warrants of $99,915 was considered as debt discount upon issuance and was being amortized as interest over the term of the notes or in full upon the conversion of the corresponding notes. During the year ended March 31, 2016, the Company amortized $9,818 of such discount to interest expense, and the unamortized discount as of March 31, 2016 was $89,727. On June 6, 2016, the Lenders converted $200,000 of principal and $5,918 of interest into 205,918 shares of the Company's common stock at a conversion price of $1 per share. As the market price of the shares on the date of conversion was approximately $1.67 per share, the Company recognized a beneficial conversion cost of $136,936. As a result of the conversion, the remaining debt discount of $89,727 was fully amortized to interest expense as of the date of conversion. As an inducement for the conversion, the Lenders were issued 205,920 warrants to purchase shares of the Company's common stock at an exercise price of $0.005 per share. The aggregate fair value of the 205,920 warrants issued to the Lenders was $341,864 using the Black-Scholes-Merton Option Pricing model with the following average assumptions: risk-free interest rate of 1.20%; dividend yield of 0%; volatility rate of 100%; and an expected life of three years (statutory term). The value of the warrants of $341,864 was considered as additional interest expense upon their issuance. The warrants were exercised immediately into 205,920 shares of the Company's common stock with net proceeds of $1,030 to the Company.

Income Tax Provision (Details)

Income Tax Provision (Details) - USD ($)	Mar. 31, 2017	Mar. 31, 2016
Income Tax Provision [Abstract]
Net operating loss carryforward	$ 6,152,000	$ 2,708,000
Stock-based compensation	912,000	343,000
Impairment of note receivable	85,000
Loss on sale of investment in OCHL	1,116,000
Equity in earnings of OCHL	(53,000)	(164,000)
Total deferred tax assets	8,212,000	2,887,000
Valuation allowance	(8,212,000)	(2,887,000)
Net deferred tax asset

Income Tax Provision (Details 1

Income Tax Provision (Details 1)	12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Income Tax Provision [Abstract]
U.S federal statutory income tax	(34.00%)	(34.00%)
State tax, net of federal tax benefit	(5.80%)	(5.80%)
Permanent differences	(65.52%)
Change in valuation allowance	105.32%	39.80%
Effective tax rate	0.00%	0.00%

Income Tax Provision (Details T

Income Tax Provision (Details Textual) - USD ($) $ in Millions	12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Tax Credit Carryforward [Line Items]
Net operating loss carryforwards expire date	Dec. 31, 2037
Federal [Member]
Tax Credit Carryforward [Line Items]
Net operating loss carryforwards	$ 15.4	$ 15.4
State [Member]
Tax Credit Carryforward [Line Items]
Net operating loss carryforwards	$ 6.8	$ 6.8

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015
Current Assets
Cash and cash equivalents	$ 1,477,229	$ 36,898	$ 36,121
Prepaid expense	21,569	15,995
Total Current Assets	1,498,798	52,893
Other Assets
Property and equipment, net	57,407	62,569
Total Assets	1,556,205	5,218,308
Current Liabilities:
Accounts payable and accrued liabilities	542,035	481,412
Note payable	277,270	262,040
Note payable, shareholder	3,603,446	2,784,000
Current portion of unsecured convertible notes, net of discount	67,858
Services payable, related party	239,080	1,000,000
Total Current Liabilities	4,729,689	4,877,311
Unsecured convertible notes - related party, net of discount	11,668
Unsecured convertible notes, net of discount and current portion	220,540	110,273
Total Liabilities	4,961,897	4,987,584
Stockholders' Deficit:
Preferred stock, $0.001 par value; 1,000,000 shares authorized; no shares issued or outstanding
Common stock, $0.001 par value; 500,000,000 shares authorized; 105,996,974 shares issued and outstanding.	103,997	91,997
Additional paid in capital	24,586,201	13,984,898
Accumulated deficit	(28,095,890)	(13,846,171)
Total stockholders' deficit	(3,405,692)	230,724	$ 2,403,311
Total Liabilities and Stockholders' Deficit	1,556,205	$ 5,218,308
Pro Forma [Member]
Current Assets
Cash and cash equivalents	1,477,229
Prepaid expense	21,569
Total Current Assets	1,498,798
Other Assets
Property and equipment, net	175,407
Intangibles	3,222,000
Total Assets	4,896,205
Current Liabilities:
Accounts payable and accrued liabilities	542,035
Note payable	277,270
Note payable, shareholder	3,603,446
Current portion of unsecured convertible notes, net of discount	67,858
Services payable, related party	239,080
Total Current Liabilities	4,729,689
Unsecured convertible notes - related party, net of discount	11,668
Unsecured convertible notes, net of discount and current portion	220,540
Total Liabilities	4,961,897
Stockholders' Deficit:
Preferred stock, $0.001 par value; 1,000,000 shares authorized; no shares issued or outstanding
Common stock, $0.001 par value; 500,000,000 shares authorized; 105,996,974 shares issued and outstanding.	105,997
Additional paid in capital	27,924,201
Accumulated deficit	(28,095,890)
Total stockholders' deficit	(65,692)
Total Liabilities and Stockholders' Deficit	$ 4,896,205

Subsequent Events (Details 1)

Subsequent Events (Details 1) - USD ($)		12 Months Ended
		Mar. 31, 2017	Mar. 31, 2016
Revenue		$ 225,000
Cost of revenue
Gross profit	[1]
Operating expenses:
Selling, general and administrative		5,349,801	3,619,000
Related party expenses		360,000	360,000
Total operating expenses		5,709,801	3,979,000
Loss from operations		(5,484,801)	(3,979,000)
Other income (expenses)
Interest expense, net		(512,152)	(178,498)
Other income		6,667
Fair value of warrants issued for note extension and inducement to convert		2,002,977
Earnings from investment in OCHL		132,832	410,553
Fair value of warrants and beneficial conversion feature on debt conversion		3,248,948
Fair value of beneficial conversion feature		136,936
Impairment of note receivable - related party		213,331
Loss on sale of investment		(2,790,073)
Total other income (expenses)		(8,764,918)	232,055
Net loss		$ (14,249,719)	$ (3,746,944)
Net Loss per common share - basic and diluted		$ (0.15)	$ (0.04)
Weighted average common shares - basic and diluted		97,596,206	90,082,796
Pro Forma [Member]
Revenue		$ 3,972,000	$ 5,744,000
Cost of revenue		1,147,000	2,052,000
Gross profit		2,825,000	3,692,000
Operating expenses:
Selling, general and administrative		9,479,801	7,297,000
Related party expenses		360,000	360,000
Total operating expenses		9,839,801	7,657,000
Loss from operations		(7,014,801)	(3,965,000)
Other income (expenses)
Interest expense, net		(497,152)	(218,498)
Other income		6,667
Fair value of warrants issued for note extension and inducement to convert		(2,002,977)
Earnings from investment in OCHL		132,832	410,553
Fair value of warrants and beneficial conversion feature on debt conversion		(136,936)
Fair value of beneficial conversion feature		(136,936)
Impairment of note receivable - related party		(213,331)
Loss on sale of investment		(2,790,073)
Total other income (expenses)		(8,749,918)	192,055
Net loss		$ (15,764,719)	$ (3,772,945)
Net Loss per common share - basic and diluted		$ (0.16)	$ (0.04)
Weighted average common shares - basic and diluted		99,596,206	92,082,796
[1]	To reflect investment in KoKo under equity method.

Subsequent Events (Details Text

Subsequent Events (Details Textual)	May 05, 2017USD ($)Officersshares	Jun. 10, 2016USD ($)$ / sharesshares	May 31, 2017USD ($)Officers$ / sharesshares	Apr. 30, 2017USD ($)Officersshares	May 31, 2017USD ($)$ / sharesshares	Mar. 31, 2017USD ($)$ / sharesshares	Mar. 31, 2016USD ($)$ / sharesshares
Number of shares issued, value							$ 5,813
warrants to purchase common stock | shares						150,000	3,600,000
Warrant exercise price (in dollars per share) | $ / shares						$ 1.67	$ 0.005
Proceeds from Related Party Debt						$ 105,000
Percentage of equity financing						50.00%
Fair value of warrants						$ 1,447,066
Unsecured Convertible Notes Payable [Member]
Total gross proceeds from securities						$ 5,000,000
warrants to purchase common stock | shares						797,500
Warrant exercise price (in dollars per share) | $ / shares						$ 0.01
Total cash principal						$ 1,595,000
Fair value of warrants						$ 723,533
Conversion price, Description						As of the issuance dates of these notes, the effective conversion price was $0.91, and the market price of the shares on the date of conversion was approximately $1.67 per share. As such, the Company expects to recognize a beneficial conversion feature of $723,533.
Trinad Capital [Member] | Senior Notes [Member]
Proceeds from Related Party Debt							95,100
Accredited Investors [Member]
Total gross proceeds from securities		$ 1,250,000					$ 1,250,000
Number of shares issued | shares		250,000
Purchase price per share (in dollars per share) | $ / shares		$ 5
Investor [Member]
Number of shares issued | shares						947,500
Number of shares issued, value						$ 9,475
warrants to purchase common stock | shares						947,500
Warrant exercise price (in dollars per share) | $ / shares						$ 0.01
Total consideration of common stock | shares						737,500
Subsequent Event [Member]
Number of shares issued | shares	2,000,000
Number of shares issued, value	$ 3,340,000
Subsequent Event [Member] | Third officer [Member]
Common stock granted shares | shares			400,000	400,000
Subsequent Event [Member] | Employment Agreements [Member] | First tranche [Member]
Shares vested | shares			200,000	200,000
Description Of Shares Vesting			Remaining number of shares vesting monthly thereafter, with 100% vesting over the 24-month term of the employment agreement.	Remaining number of shares vesting monthly thereafter, with 100% vesting over the 24-month term of the employment agreement.
Subsequent Event [Member] | Employment Agreements [Member] | officer [Member]
Officers annual salary			$ 120,000	$ 120,000
Officers annual salary term			2 years	2 years
Number of officers | Officers			2	2
Common stock granted value			$ 501,000	$ 501,000
Common stock granted shares | shares			300,000	300,000
Subsequent Event [Member] | Employment Agreements [Member] | Second officer [Member]
Number of shares issued, value			$ 668,000	$ 668,000
Officers annual salary			$ 180,000	$ 180,000
Officers annual salary term			2 years	2 years
Number of officers | Officers			2	2
Common stock granted value			$ 501,000	$ 501,000
Common stock granted shares | shares			300,000	300,000
Bonus received			$ 100,000	$ 100,000	$ 100,000
Bonus received shares | shares			2,000,000	2,000,000
Subsequent Event [Member] | Management Agreement [Member]
Related party due services payable				$ 1,000,000
Debt term				3 years
Subsequent Event [Member] | 6% unsecured convertible note payables [Member]
Purchase price per share (in dollars per share) | $ / shares			$ 0.01		$ 0.01
Subsequent Event [Member] | Investor [Member]
warrants to purchase common stock | shares			2,880,539		2,880,539
Subsequent Event [Member] | Institutional Investor [Member]
Total gross proceeds from securities					$ 5,000,000
Subsequent Event [Member] | Wantickets [Member]
Description of notes due	Net income of $3 million in the twelve months following the effective date of his employment agreement or net income of $4 million in the twelve months thereafter.
Total consideration of common stock | shares	2,000,000
Business acquisition, description	Pursuant to the APA and the Letter Agreement, dated as of May 5, 2017 (the "Letter Agreement"), entered into among the Company, LXL Tickets and Mr. Schnaier, the parties agreed that, commencing May 5, 2017, Mr. Schnaier will promptly pay for all of LXL Tickets' net losses of its business for each calendar month (or pro rata thereof), up to a total of $100,000 per month, and for any liabilities exceeding $100,000 in the aggregate that arose from April 1, 2017 to May 5, 2017 (inclusive), until the earlier of (x) such time as a public offering is consummated or (b) May 5, 2018 (such earlier date as between clause (x) and (y).
Subsequent Event [Member] | Wantickets [Member] | officer [Member]
Officers annual salary	$ 220,000
Officers annual salary term	2 years
Number of officers | Officers	2
Subsequent Event [Member] | Wantickets [Member] | Other officer [Member]
Officers annual salary	$ 160,000
Common stock granted shares | shares	15,000